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Abstract 
While the expert consensus seems to be that 3 to 5% of adults suffer from Attention-
Deficit/Hyperactivity Disorder (ADHD), the validity of this prevalence is still uncertain, 
given wide ranging estimates.  One potentially important tool for accurately identifying 
ADHD in both children and adults is neurocognitive testing.  The Central Nervous 
System Vital Signs (CNSVS) is a new, brief battery of computerized neurocognitive tests 
with putative value for the assessment of ADHD.  Drawing from a community-derived 
sample of 702 adults (ages 18 to 85 years), this study examines whether the CNSVS 
differentiates individuals with clinically elevated ADHD symptoms (n = 61) from those 
with similarly elevated depression (n = 31) and anxiety (n = 21) and others with non-
elevated scores (n = 589).  Scores on the CNSVS were compared to self report measures 
of ADHD, depression, and anxiety to help establish the concurrent and convergent 
validity of this novel instrument.  Overall, the CNSVS did not differentiate between 
ADHD, depression, anxiety, and control groups.  An exploratory analysis did show a 
trend level difference between groups when restricting the age of participants to 40 years 
or younger, Λ = .767, F (3, 256) = 1.295, p = .086; however, ironically, the ADHD-U 
group fared better than peers in the comparison groups on two outcome variables, which 
accounted for this result.  The findings are generally consistent with a body of prior 
research suggesting that measures of neurocognitive deficits in child, adolescent, and 
young adult ADHD groups inconsistently provide additional diagnostic certainty, and 
specifically indicate that the CNSVS battery does not effectively differentiate ADHD 
from other groups in a community sample across adulthood. 
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The Utility of CNS Vital Signs as an Indicator of Adult ADHD 
Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by three key 
symptom clusters: developmentally inappropriate levels of (1) inattention, (2) 
hyperactivity, and (3) impulsivity.  Affected individuals typically first display such 
symptoms in early childhood, and the condition is associated with broad reaching and 
persistent dysfunction in several domains of life (e.g., education, work, relationships; 
Fischer, Barkley, Smallish, & Fletcher, 2005).  
 Prevalence reports for ADHD in both school-aged children and adults vary 
widely.  Estimates ranging from 3 to 5% (Buitelaar, 2002) to 8.7% (Froehlich et al., 2007) 
and even up to 10% (Scahill & Schwab-Stone, 2000) have characterized the proportion of 
school-aged children in the United States meeting Diagnostic and Statistical Manual of 
Mental Disorders (4th edition, text revision; DSM-IV-TR; American Psychiatric 
Association, 2000) criteria for the disorder.  Similarly varied prevalence estimates are 
noted across countries and cultures (Faraone, Sergeant, Gillberg, & Biederman, 2003).  
Persistence of ADHD from childhood to adulthood varies with diagnostic methods as 
well.  Barkley, Fischer, Smallish, and Fletcher (2002) note that self-report measures 
estimate persistence of ADHD into adulthood at 5 to 6%, whereas parent report measures 
increase the estimate to 46%.  Barkley and colleagues (2002) further report that rate to 
increase to 66% for parent reports when developmentally referenced criteria are included.  
Several other studies have reported estimates of up to 80% persistence into adulthood 
(August, Stewart, & Holmes, 1983; Barkley, Fischer, Edelbrock, & Smallish, 1990; 
Claude & Firestone, 1995; Gittelmann, Mannuzza, Shenker, & Bonagura, 1985).   
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The identification of ADHD in adults is a problematic task, however.  Barkley, 
Murphy, and Fischer (2008) point out that the current DSM-IV-TR symptom criteria was 
developed and normalized only on children.  Accordingly, the appropriateness of these 
symptom criteria for adult populations is questionable.  Barkley and colleagues (2008) 
maintain that symptom presentation in adult ADHD is significantly different from 
childhood, which would make the DSM-IV-TR symptom criteria inappropriate for at 
least some adult clients. 
Domains of Impairment Associated with ADHD 
 Individuals with ADHD experience impairment in several areas of life.  Children 
with ADHD have been shown to have more general health problems (Hartsough & 
Lambert, 1985).  Later in life, impairment has also been found in driving-related 
activities, employment, substance use, and life expectancy (Barkley, 2006).  Among the 
most commonly cited domains of impairment for individuals with ADHD are academics, 
physical safety and relationships.  
Academics. Children with ADHD often suffer from poor academic performance 
and achievement (Barkley, 2006).  Performance refers to actual productivity in school 
work, whereas achievement refers to grade level proficiency.  Barkley (2006) cites 
several studies (Barkley, DuPaul, & McMurray, 1990; Brock & Knapp, 1996; Cantwell 
& Satterfield, 1978; Casey, Rourke, & Del Dotto, 1996; Dykman & Ackermann, 1992; 
Fischer, Barkley, Fletcher, & Smallish, 1990; Semrud-Clikeman et al., 1992) to establish 
that children with ADHD tend to score much lower on standardized achievement tests 
than do peers without ADHD.  These studies found that children with ADHD scored 10-
30 standard points below the mean for non-diagnosed classmates.  Frazier, Demaree, and 
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Youngstrom (2004) conducted a meta-analysis of 24 studies testing reading achievement, 
15 studies testing spelling, and 21 studies testing math achievement in groups of children 
with and without ADHD.  This study calculated a weighted mean effect size for each 
academic area to illustrate the difference between the ADHD and control groups.  Frazier 
and colleagues (2004) found an effect size of 0.64 (95% Confidence Interval [CI] of .53-
.75) for measures of reading achievement, 0.87 (95% CI of 0.72-1.02) for spelling 
achievement, and 0.89 (95% CI of .78-100) for math achievement.   
These findings contrast other research suggesting that children with ADHD tend 
to score no differently from peers without ADHD on measures of IQ (MTA Cooperative 
Group, 1999; Doyle, Biederman, Seidman, Weber, & Faroane, 2000).  Using the 
Wechsler Intelligence Scale for Children (WISC-III), the MTA Cooperative Group found 
that the adjusted mean Full Scale IQ (FSIQ) score for children with ADHD was 98.45.  
Schuck and Crinella (2005) point out that when researchers do find lower IQ scores for 
children with ADHD there are only a few subtests depressing the scores. The subtests 
that children with ADHD tend to perform worse on include Arithmetic, Coding, 
Information, and Digit Span.  These subtests are associated with executive functions (Loo 
et al., 2007).  Schuck and Crinella (2005) compared FSIQ scores to three measures of 
executive functioning (Impulsivity, Perseveration, Fail set errors) in 123 males from 7-13 
years old.  The results showed relatively small correlations between measures of 
executive functioning and FSIQ scores (IMPULS, r = .07; PERSEV, r = –.22; and 
FAILSET, r = .19).  Schuck and Crinella (2005) contend that children with ADHD may 
experience deficits in executive functioning that are not related to an overall IQ score.      
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Physical safety. Individuals with ADHD are also more likely to suffer from 
accidental injuries than unaffected peers.  Szatmari, Offord, and Boyle (1989) studied a 
sample of 2,600 children, finding that 7.3% of children with ADHD suffered from an 
accidental poisoning and 23.2% suffered from bone fractures, whereas only 2.3% of 
control group children suffered accidental poisoning with 15.1% suffering from bone 
fractures.  Barkley, Guevremont, Anastopoloulos, DuPaul, and Shelton (1993) surveyed 
parents about the driving experiences of their teenage and young adult children.  The 
study found that teenagers and young adults with ADHD were more likely to have driven 
a car before obtaining a legal license, have their license suspended or revoked, receive 
repeated speeding tickets, and were four times more likely to be involved in an accident 
as compared to a non-diagnosed control group.  Adults with ADHD are also more likely 
to have lower self esteem, less education, less marital success, greater difficulties in 
occupational functioning, and make poorer health choices (Murphy & Barkley, 1996).   
Relationships. Social and peer relationships comprise another common domain of 
impairment for children and adults with ADHD.  Several studies report findings that 
suggest approximately 50% of children diagnosed with ADHD suffer significant rejection 
by their peers (Gaub & Carlson, 1997; Guevremont & Dumas, 1994; Barkley, 1990).  
Unnever and Cornell (2003) conducted a study of 1,315 middle school students and 
found that children with ADHD were more likely to participate in bullying behaviors as 
well as be victimized by bullies.  This study found that 13% of children with ADHD 
engaged in bullying as compared to 8% of non-diagnosed controls.  Also, 34% of 
children with ADHD were victims of bullying as compared to 22% of non-diagnosed 
controls.  Mikami and Hinshaw (2003) found that girls with ADHD had a tendency to 
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show more aggression and related difficulties sustaining relationships, reinforcing that 
significant relational impairment is not limited to males with the disorder.    
 Barkley (2006) notes that a longitudinal study examining social skills in children 
with ADHD (Weiss & Hechtman, 1993) found that by adulthood these individuals had 
more difficulty with heterosocial interactions as compared to non-diagnosed peers.  
Individuals with ADHD also show greater marital dissatisfaction and are more likely to 
enter into multiple marriages (Barkley & Murphy, 1996).  Robin and Payson (2002) 
surveyed 80 married couples with one ADHD spouse and one non-ADHD spouse.  This 
study found that sources of dissatisfaction in the marriage included inattention to the 
partner, careless or impulsive communication styles, forgetfulness, and outbursts of anger 
or frustration.  Canu and Carlson (2003) examined heterosocial outcomes of male college 
students with ADHD Combined type (ADHD-C) and ADHD Primarily Inattentive type 
(ADHD-IA) as compared to a non-diagnosed control group.  Using questionnaires and 
behavioral observations, this study found that the ADHD-IA group was passive and 
inexperienced in their social interactions, whereas the ADHD-C group reported a greater 
sexual drive and earlier dating experiences.     
Behavioral Inhibition, Executive Functions, and ADHD 
 Behavioral inhibition is hypothesized to be the core deficit across the three 
symptoms clusters of ADHD (Barkley, 2006).  The function of behavioral inhibition is to 
suppress both inappropriate responses to an environment and interference from 
extraneous stimuli (Schulz, Tang, Fan, Marks, & Cheung, 2005).  Barkley (2006) 
proposes three interrelated processes that comprise behavioral inhibition.  The first 
process is the inhibition of a prepotent or automatic response to an event.  The second 
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process involves termination of an ongoing response, and the third process protects the 
time before a response from competing or distracting events.  These three actions are 
believed to facilitate a period of delay between an event and the individual’s response to 
the event.  The period of delay is important because it allows for consideration of 
possible errors and greater flexibility to responses related to any particular task (Barkley, 
2006). 
The three behavioral inhibition processes are categorized as “executive” cognitive 
functions (Barkley, 2006).  The primary purpose of executive functioning is to mediate 
an internal focus of behavior to develop appropriate responses to current and future 
events.  Executive functions can be equated to self-regulation, in that they allow one to 
anticipate change in the environment and then guide the individual’s response to optimize 
future outcomes.  These subsequent behaviors are seen as goal-directed and intentional.  
Barkley theorizes that executive functions begin early in life as behaviors directed 
towards others and are internalized as the child develops.  Four stages in the development 
of executive functioning are proposed:  The internalization of behavior, a shift from 
controlling others to controlling oneself, a shift from present oriented behaviors to future 
goal-directed behaviors, and an increasing sensitivity to the importance of delayed 
consequences over immediate consequences. 
Four cognitive functions that appear to support the process of behavioral 
inhibition include nonverbal and verbal working memory, self-regulated emotions or 
mood, and planning (Barkley, 2006).  Nonverbal working memory is important in 
maintaining previously perceived information that will be used in the consideration of 
subsequent responses to the environment.  The two sets of data that are processed by 
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nonverbal working memory are visual images and auditory stimuli.  Verbal working 
memory, on the other hand, is best conceptualized as an internalization of speech.  
Internal speech is important for the development of self control and is also utilized in 
problem solving, reading comprehension, rule governed behavior, description, and 
reflection.  The ability to regulate one’s emotions is important because all external events 
elicit some sort of emotional response, which is often followed by an associated motor 
response.  A period of delay, which is considered self-regulatory, permits such a 
prepotent response (e.g., hitting associated with anger) to be modified by the individual in 
consideration of future outcomes.  Planning involves the analysis and synthesis of 
information.  Analysis involves the separation of sequences of behavior into individual 
parts.  Synthesis involves the reorganization of these sequences into novel responses.  
Together, all of these functions serve to inhibit inappropriate responses and maximize the 
benefits of future outcomes. 
Working memory deficits associated with ADHD in neurocognitive tasks. Of the 
four executive functions that have been linked to ADHD, the preponderance of research 
has focused on working memory.  Working memory both maintains and manipulates 
information in one’s awareness.  Such cognitive functions are seen as problematic for 
individuals with ADHD (Diamond, 2005).  Baddeley (2003) proposed a model of 
working memory that is comprised of two independent functions that are overseen and 
maintained by a central executive (CE) system.  The two systems are know as the 
phonological loop (PH), which processes auditory data, and the visuospatial sketch pad 
(VS), which  processes visual information.  Each has a unique mode of acquiring 
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information, a buffer which stores information temporarily, and a mechanism for 
rehearsal of information.    
Rapport and colleagues (2008) measured VS working memory through a 
computerized task asking participants to encode and repeat a particular spatial sequence.  
PH working memory was measured through a computerized presentation of letters and 
numbers and asking the participants to repeat the sequence back.  CE working memory 
was assessed by analysis of these two scores.  The results of this study show that children 
with ADHD performed significantly worse than normal control participants for PH tasks 
with a Hedges’ g effect size of 1.89 standard deviation units (95% CI = 1.80 - 1.98).  
Similar results were found for the VS tasks, where children with ADHD performed 
significantly lower than the control group (g = 0.89, 95% CI = 0.80-0.98).   
Two separate meta-analyses also found significant working memory deficits for 
children with ADHD.  Martinussen, Hayden, Hogg-Johnson, and Tannock (2005) 
analyzed 26 studies published from 1997 to 2003 and found an overall effect size for VS 
of 0.85 (95% CI = 0.62 – 1.08), and an effect size of PH of 0.47 (95% CI = 0.36 – 0.59) 
when comparing non-diagnosed to ADHD groups.  Further, Martinussen and colleagues 
(2005) found these results to be independent of co-occuring learning disorders.  Willcutt, 
Doyles, Nigg, Faraone, and Pennington (2005) analyzed 83 studies and found moderate 
executive functioning deficits in individuals with ADHD, with reported effect sizes for 
all studies falling between .46 and .69. 
Schoechlin and Engel (2005) conducted a meta-analysis measuring neurological 
performance in adults with ADHD as compared to control groups.  This analysis 
examined 24 empirical studies and compiled findings of 50 commonly used 
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neuropsychological tests.  Poorer performance was found in the ADHD groups across 10 
domains.  These domains were Verbal Intelligence (d = -0.27), Executive Functions (d = 
-0.21), Visual/verbal fluency (d = -0.52), Visual/figural problem solving (d = -0.26), 
Abstract problem solving and working memory (d = -0.51), Simple attention (d = -0.38), 
Sustained attention (d = -0.52), Focused attention (d = -0.55), Verbal memory (d = -0.56), 
and figural memory (d = -0.18). 
Behavioral inhibition deficits associated with ADHD in neurocognitive tasks. The 
Stoop Word-Color Test is often used as a measure of executive functioning deficits in 
individuals with ADHD, and is specifically designed to measure response (i.e., 
behavioral) inhibition.  This is done by having individuals read the name of a color, 
though the word is printed in a different colored ink (e.g., the word green would be 
printed in red ink). This task requires information to be stored and processed 
simultaneously, engaging working memory.  Several versions of the Stroop Test exist.  
The Golden version (Golden, 1978) poses three conditions to the participant.  The first 
condition presents a card (word card) that measures the speed of reading the words 
written on it.  Four different words (red, green, yellow, and blue) are printed on the card.  
The second card (color card) asks the participant to name the color of several Xs that are 
printed in red, green, yellow, and blue ink.  The third card (color-word card) asks 
participants to read color words that are printed in a different color ink.  For this task, 
interference occurs when the word on the third card is read incorrectly.   
A popular measure of motor inhibition in individuals with ADHD is Conners’ 
Continuous Performance Test (Conners, 1994).  Conners’ Continuous Performance Test 
(CPT) presents a target stimulus on a computer screen, with responses given through 
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pressing a button on a keyboard.  This task is designed to measure inhibitory control as it 
requires the participant to correctly respond to stimuli presented rapidly while also 
inhibiting responses to non-targeted stimuli. Riccio, Reynolds, Lowe, and Moore (2001) 
conducted a meta-analysis and found a mean effect size of 1.46 for individuals with 
ADHD to have similar impairments, such as traumatic brain injury, when compared to 
control groups. 
Most of the studies examining adult outcomes for those with ADHD have paid 
little attention to executive functioning and other cognitive deficits.  Adults with ADHD 
are believed to have intellectual functioning that is roughly equal to that of the general 
population (Bridgett & Walker, 2006).  Neurocognitive testing, however, has been shown 
to be an effective means for differentiating adults with ADHD from control groups.  
Lovejoy and colleagues (1999) showed that neuropsychological tests may be able to 
identify adults with ADHD.  Using the Stroop task and other measures of executive 
functioning, this study found significantly poorer performance in tasks testing inhibition, 
shifting attention, and working memory.  These finding suggests that there may be some 
use for neurocognitive tests as screening tools for ADHD in adulthood.   
Assessment of Adult ADHD  
ADHD is viewed primarily as a childhood disorder.  However, evidence suggests 
a prevalence of approximately 4% among adults in the United States (Kessler et al., 
2006).  Still, identifying these adults with ADHD—particularly those not diagnosed in 
childhood—is often complicated, given that the onset of symptoms must be established 
as occuring before age seven.  This is made more difficult in that diagnosing a referred 
adult with ADHD often relies on subjective, self-reports reports of past experience, as 
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many are unable to provide tangible evidence of the disorder in early childhood 
(McGough & Barkley, 2004).  Further, as noted above, the DSM-IV-TR criteria are 
composed of symptoms that may be more developmentally appropriate for children than 
for adults (Barkley, 2006).  Adults cannot be expected to have impairments in behaviors 
that they rarely exhibit (e.g., difficulty in playing quietly or running and climbing 
excessively).  There is also evidence that a six symptom threshold is inappropriate for 
identifying ADHD in adults.  A prevalence study of ADHD symptom criteria from the 
DSM-IV in a group of adults found that a six symptom threshold for a diagnosis was two 
to four standard deviations above the mean number experienced for adults with ADHD 
(Murphy, & Barkley, 1996).  A later study confirmed this finding, noting the six 
symptom threshold for hyperactivity to be 3.5 standard deviations above the adult mean 
(Barkley, Fischer, Smallish, & Fletcher, 2002). 
Barkley (2006) identifies three more issues that make identifying ADHD in adults 
difficult.  First, individuals presenting for clinical services are apt to attribute inattention, 
hyperactivity, and impulsivity to ADHD rather than other conditions or exacerbating 
events. Second, from a professional diagnostic perspective, most of the Axis I disorders 
in the DSM-IV-TR include inattention as a symptom. Barkley identifies inattention as a 
“global marker” for any form of distress.   Hyperactivity is also represented in both Axis 
I and Axis II conditions and is thus associated with complications in differential 
diagnosis.  Finally, Barkley views ADHD as falling on a continuum, where the difference 
between an individual diagnosed with ADHD and an individual who does not receive a 
diagnosis is often arbitrary.  Personal judgment is often used when making the final 
decision of a diagnosis, thus increasing the likelihood of error and inconsistency.  Given 
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this set of diagnostic challenges, objective, standardized neurocognitive tests that 
measure underlying dysfunctions associated with ADHD would be ideal for the 
assessment of adult clients.   
Central Nervous System Vital Signs battery and ADHD 
The Central Nervous System Vital Signs (CNSVS) is computerized testing battery 
developed to be a brief measure of numerous clinical conditions.  The benefits of such 
measures are that they allow for the assessment of neurological impairment in a relatively 
quick, efficient, and cost effective manner.  They also allow for more consistency in 
administration and scoring, which may increase reliability.  Finally, the CNSVS is 
intended to provide substantial and valid indicators of cognitive impairment.  Initial 
research by the developers, Gualtieri and Johnson (2006a), suggests that the CNSVS is 
able to identify dementia, brain injury, depression, and ADHD.  Their study used a 
community sample of 1069 participants with ages ranging from seven to ninety to create 
a normative database for scores on the CNSVS.  In another study, Gualtieri and Johnson 
(2006b) used a cross-sectional design to examine the performance of individuals with 
ADHD from ages 10 to 29.  This study found that individuals with ADHD performed 
worse than age matched controls on the CNSVS in the domains of psychomotor speed, 
reaction time, cognitive flexibility, and attention.  These impairments were found across 
childhood, adolescents, and young adults.   
The CNSVS is comprised of seven different computerized tests that are based on 
well established tests of executive functions and other neurocognitive abilities.  The 
seven tests include Verbal Memory (VBM), Visual Memory (VSM), Finger Tapping Test 
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(FTT), Symbol Digit Coding (SDC), the Stroop Test, the Shifting Attention Test (SAT), 
and the Continuous Performance Test (CPT) (Gualtieri & Johnson, 2006a).   
CNSVS Verbal Memory test and related measures. The VBM test requires a 
participant to learn word lists.  A total of 15 words in all are presented with one word 
presented every two seconds (Gualtieri & Johnson, 2006a).  The participants are then 
asked to remember the 15 words, which are randomly mixed into a list of 30 words for 
recognition.  Participants are asked to press the spacebar every time they see a word from 
the original list.  Recognition is tested again at the end of the CNSVS (approximately 20 
minutes later) using the original 15 target words and 15 new non-target words.  The 
Bushke Selective Reminding Test (Bushke & Fuld, 1974) is a 12 item list learning task, 
which is similar to the VBM, asks participants to perform a similar function.  Participants 
in this task are tested for recall of words rather than recognition and are therefore not 
presented with words to cue memory.  Solanto and colleagues (2007) found that 
individuals with ADHD combined type performed worse on Bushke indices of total recall, 
long-term storage and long-term retrieval, as compared to non-diagnosed peers (partial 
eta squared effect sizes = 0.093, 0.095, 0.099, respectively).  Individuals with ADHD 
Inattentive (ADHD-IA) and Combined (ADHD-C) types also performed worse than 
controls on delayed recall (partial eta squared = 0.102).  The California Verbal Learning 
Test (CVLT), which also measures an individual’s aptitude for list learning (Delis, 
Kaplan, & Ober, 1987), has been shown to be sensitive to identifying adults with ADHD.  
Jenkins and colleagues (1998) found that adults who had been identified as having ADD 
as a child performed worse than adults without childhood ADD on CVLT learning trials 
(d = -0.71) and during delayed recall (d = -0.75).  Gallagher and Blader (2001) also report 
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slower psychomotor processing and memory decrements for individuals with ADHD on 
the CVLT (Holdnack, Moberg, & Arnold, 1995 as cited by Gallagher and Blader, 2001).  
Lovejoy and colleagues also found that adults with ADHD performed more poorly on the 
CVLT than did controls (d = -0.52).    
 CNSVS Visual Memory test and related measures. The VSM test is similar to the 
VBM, except that participants are asked to remember geometric figures instead of words 
(Gualtieri & Johnson, 2006a).  Like the VBM, the VSM requires participants to 
memorize 15 figures and then recognize them from a list of 30 figures.  The recognition 
list contains 15 target figures and 15 non-target figures mixed randomly.  A delayed 
recognition measure is also taken after five other tests have been given.  The Benton 
Visual Retention Test is designed to measure an individual’s ability to perceive and 
remember geometric figures (Golden, Espe-Pfeifer, & Wachsler-Felder, 2000).  Dige and 
Wik (2005) found that adults who were diagnosed with ADHD performed more poorly 
than did controls on correct responses (d = 0.87) and errors (d = 1.65).   
The CNSVS and other Stroop tests. As noted above, the Stroop Test has been 
published in several forms (Gualtieri & Johnson, 2006a).  In the CNSVS, the Stroop Test 
has three components.  The first part presents the words RED, YELLOW, BLUE, and 
GREEN one at a time in random order.  The participant is asked to press the spacebar as 
soon as the word appears in order to produce a reaction time score.  The second part of 
the test presents the same words.  The words, however, are presented in colors.  
Participants are asked to press the spacebar only when the word presented matches the 
color that it is presented in.  The score generated for this task is known as a complex 
reaction time.  The final part of this test presents words in the same manner as the second 
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part of the test.  Participants are asked to press the spacebar when the color and word are 
not matched.  This final part also generates a complex reaction time.  The reaction time 
for the third portion is generally 120 milliseconds longer than the reaction time in the 
second portion.  The two complex reaction time scores are averaged together to 
determine an individual’s speed of information processing.  In their meta-analysis of 
neurological test performance of ADHD, Frazier and colleagues (2004) found an effect 
size of 0.56 between individuals with ADHD and non-diagnosed controls on the Stroop 
Task.  This effect size was calculated specifically for the interference portion of the test.  
Lovejoy and colleagues (1999) found that adults with ADHD performed more poorly 
than did controls on the Stroop Neuropsychological Screening Test (Trennery, Crosson, 
DeBoe, & Leber, 1988).  This study found a Cohen’s d of -1.18.  Though several studies 
have shown versions of the Stroop Test to be sensitive to executive functioning 
differences in individuals with ADHD, others have concluded that this measure cannot 
provide an accurate diagnosis of ADHD in itself (Homack & Riccio, 2004; Mourik, 
Oosterlann, & Sergeant, 2005).  
 CNSVS Shifting Attention Task and related measures. The SAT requires 
individuals to shift from following one set of instructions to another quickly.  Participants 
are asked to match geometric figures by either shape or color, with the requirements 
changing randomly (Gualtieri & Johnson, 2006a).  The test last for 90 seconds with the 
goal being for participants to match as many items correctly in the allotted time.  The 
SAT measures correct answers, incorrect answers, and response time.  The SAT closely 
resembles the Wisconsin Card Sorting Task (WCST), which measures one’s ability to 
form and shift a cognitive representation (Berg, 1948).  Solanto and colleagues (2007) 
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found that children meeting criteria for ADHD combined and ADHD inattentive 
performed more poorly than did controls (partial eta squared = 0.073) on the WCST.  The 
also found that the two ADHD groups needed more trials to correctly identify a category 
(partial eta squared = 0.046), and were less perseverative in their responses (partial eta 
squared = 0.049).  Further, Jenkins and colleagues (1998) found that adults who were 
identified with ADD as children performed more poorly on the WCST than did adults 
who were not identified with ADD as children (d = -0.395).      
       CNSVS and other Continuous Performance Tasks. The CPT measures sustained 
attention and vigilance (Gualtieri & Johnson, 2006a).  In the CNSVS version of the CPT, 
participants are required to respond to the presentation of the letter “B” but not the 
presentation of any other letter.  The test presents 200 letters of the course of five minutes.  
The target stimulus “B” is presented 40 time in all.  Though the presentation is 
randomized, the targets stimuli are presented 8 times for every minute of the test.  The 
test records three scores.  The first is the number of correct answers.  The two error 
scores are responses to incorrect stimuli (impulsivity), and target stimuli that are not 
responded to (inattention).  Research suggests that CPTs are able to discriminate 
individuals with ADHD from non-diagnosed control groups (Fischer et al., 2005; Preston, 
Fennell, & Bussing, 2005).  These studies, however, also revealed that CPTs are not as 
useful in discriminating individuals with ADHD from groups with sub-clinical symptoms 
of inattention and hyperactivity or between subtypes of ADHD.  Solanto and colleagues 
(2007) found that individuals with ADHD-C had slower reaction times to targets, greater 
deleterious effects in reaction times as the task progressed, and greater deficits in an 
index of attentiveness.  Fischer and colleagues (2005) found that individuals with ADHD 
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made significantly more commission and omission errors.  They also found that both 
types of errors did not differentiate individuals with ADHD from individuals with sub-
clinical symptoms of hyperactivity.  Preston and colleagues (2005) conclude that CPTs 
may still be useful in research to identify sample groups.     
Other CNSVS neurocognitive measures. The SDC is a timed task that requires 
participants to refer to a key that connects numbers (2-9) with corresponding symbols 
(Gualtieri & Johnson, 2006a).  The number/symbol pairs are presented at the top of the 
screen while a row of symbols without a corresponding number are presented below.  
Participants are asked to type in the proper number for each symbol.  The test last for 120 
seconds with the correct score being measured by the number of correctly coded symbols.  
Participants are also given a practice trial in order to learn how to complete the task.  Loo 
and colleagues (2007) used the Symbol Digit Coding subtest of the Wechsler Adult 
Intelligence Scale (WAIS-III) to compare Finnish adolescents with ADHD to a control 
group.  This study found that the ADHD group performed worse than controls on this 
task (Cohen’s f squared = 0.37).    
  The FTT measures an individual’s fine motor control and, while commonly used 
in neuropsychological research (Gualtieri & Johnson, 2006a), analogous tasks have not 
previously been used to examine differences between ADHD and other groups.  In the 
FTT, participants press a spacebar with their right index finger as often as the can in 10 
seconds.  They repeat the process with their left index finger.  There is one practice trial 
and three test trials.  A participant receives a score based on the average number of taps 
in all six trials. 
The Current Study 
                                                                                                             Utility of CNSVS                  20
In the present study, a community sample of 1044 young to elderly adults 
underwent and administration of the CNSVS.  The primary purpose of this study was to 
replicate that normative data on the CNSVS.  The first hypothesis is that results from this 
study will resemble that of Gualtieri and Johnson (2006a) in terms of mean scores on the 
subtasks showing mild cognitive deficits.  The utility of the CNSVS as a measure of 
ADHD in adulthood will also be examined.  The second hypothesis is that adults with 
ADHD will have deficits in executive functioning as measured by the CNSVS, as 
compared to other participants.  Individuals with ADHD will be identified according to 
scores on self-report diagnostic measures; scores on the latter will also be directly 
correlated with relevant scores on the CNSVS, providing further evidence for convergent 
validity. 
Method 
Participants 
 One-thousand-forty-four individuals, ranging from 18 to 85 years of age (female 
to male ratio is approximately 3:2), participated in the study, which was part of a larger 
investigation examining the effects of an antioxidant regimen on physical and 
psychological health.  From this participant pool, 702 were included in the current 
analyses.  Participants were excluded for having incomplete CNSVS data (n = 48), 
ADHD data (33), or BSI data (49).  Another 72 participants were excluded for having 
elevated depression and anxiety in the absence of elevated ADHD symptoms (see below).  
Finally, 140 participants were excluded for reporting subclinical levels of anxiety or 
depression in the absence of ADHD (see further details on exclusion criteria below). 
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All data utilized here were collected at baseline, before randomized intervention 
or placebo exposure.  Participants were volunteers from the community, who learned of 
the study via print, email, and other advertisements, and were financially compensated 
for their participation ($300 for three-month intervention trial).     
Design 
Participants completed study measures in two cohorts of similar size (e.g., 
approximately 520), one of which completed the study in the winter of 2008, and another 
in the autumn of that same year.  The criterion groups in this study include an ADHD 
Primarily Inattentive type group (ADHD-IA; n = 34), an ADHD Combined and Primarily 
Hyperactive-Impulsive type group (ADHD-HI, n = 27), two clinical comparison groups 
(depression, CCD, n = 31 and anxiety, CCA, n = 21), and a control group (n = 589).  
These groups were identified by self-report surveys, which assessed symptoms of ADHD 
and other psychological disorders (see below for complete details; also see Table 1for 
further demographic and diagnostic description).   
ADHD was defined using current (i.e., past six months) self symptom reports.  
Individuals were included in the ADHD groups based on Barkley and Murphy’s (2006) 
1.5 standard deviation cutoff for ADHD symptom prevalence (see below), with those in 
the ADHD-IA group reporting only elevated IA symptoms and those in the ADHD-HI 
group reporting elevated HI symptoms with or without elevated IA.  In addition, 
participants had to endorse experiencing impairment related to their current ADHD 
symptoms as being either “often” or “very often.”  The potential symptomatic expression 
of other common disorders (i.e., anxiety, depression) was measured using the Brief 
Symptom Inventory (BSI, see below; Derogatis, 1993). Individuals without ADHD (as 
                                                                                                             Utility of CNSVS                  22
defined previously) who reported elevated BSI depression were assigned to the CCD 
group, and those with elevated BSI anxiety were assigned to the CCA group.  For sake of 
comparative clarity, participants with both elevated anxiety and depression, in the 
absence of elevated ADHD symptoms, were excluded from analysis.  Given the 
substantial Axis I comorbidity rates for individuals with ADHD, those who met criteria 
for inclusion in one of the ADHD groups who also have elevated (i.e., t score ≥ 65) BSI 
depression or anxiety were not excluded and were retained as ADHD participants.  Of the 
participants included in the ADHD groups, 18 (29.5%) reported elevated levels of anxiety 
and depression, 8 (13.1%) reported elevated levels of anxiety, and 7 (11.5%) reported 
elevated levels of depression.  In all, 33 (54%) participants in the ADHD-U group 
reported comorbid anxiety, depression, or both. The control group was composed of 
participants who scored within one standard deviation of the mean for depression, anxiety, 
and ADHD as measured by the BSI and the ADHD self report survey.     
Measures 
ADHD Self-report (Current Symptom and Childhood Symptom Scales, Barkley, 
Murphy, & Fischer, 2006; adult executive dysfunction symptoms, Barkley et al., 2008).  
The ADHD self report survey consists of three portions.  The first portion assesses 
current gross ADHD impairment according to DSM-IV-TR symptom criteria as well as 
sluggish cognitive tempo, a cognitive style often associated with the Primarily Inattentive 
ADHD Type (Barkley & Murphy, 2006).  There are 22 items in this portion with 4 
response options (Never, Sometimes, Often, Very Often), including one that broadly asks 
for frequency of impairment due to these symptoms.  The second portion assesses current 
ADHD symptoms using seven additional items identified recently by Barkley and 
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colleagues (2008) as being more developmentally appropriate for adults with ADHD.  
The final portion of the survey assesses child symptoms according to the DSM-IV-TR 
criteria including age of onset.  Clinically-elevated (+1.5 SD) symptom thresholds are 
normed across age groups and symptom clusters (Inattention, Hyperactive-Impulsive, 
Total ADHD Score).  For the Inattention cluster, ages 17-29 years have a cutoff of 13, 
ages 30-49 have a cutoff of 12, and ages 50+ have a cutoff of 10.  For the Hyperactive-
Impulsive cluster ages 17-29 have a cutoff of 16, ages 30-49 have a cutoff of 13, and ages 
50+ have a cutoff of 10.  For the Total ADHD Score, ages 17-29 have a cutoff of 28, ages 
30-49 have a cutoff of 24, and ages 50+ have a cutoff of 18.  Items assessing inattentive 
symptoms, hyperactive/impulsive symptoms, and adult symptoms are listed in Appendix 
A.  For this sample, Inattentive symptoms have a Cronbach’s alpha (α) of .89 while the α 
for Hyperactive symptoms is .85. 
Brief Symptom Inventory.  The BSI provides a broad picture of an individual’s 
current symptoms and the severity of those symptoms.  The BSI is a self-report measure 
with 53 items rated on a 5 point scale.  The scale measures the level of distress that each 
item holds for the participant and ranges from “not at all” (0) to “extremely” (4).  The 
BSI is a measure of current psychological symptom experience and therefore does not 
measure chronic or persistent symptoms.  It is appropriate for use on clinical and medical 
populations as well as community respondents (Derogatis, 1993).  This scale was 
designed to be a short form of the Symptom Checklist-90-Revised (Derogatis & Cleary, 
1977).  Derogatis (1993) reported correlations between the two measures as .95 for both 
the anxiety and depression clusters.  The BSI includes 9 symptom scales; those used in 
the current study are depression (α= .85, 2-week test-retest = .84) and anxiety (α= .81, 2-
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week test-retest r = .79; Derogatis, 1993).  Items assessing symptoms of depression and 
anxiety are listed in Appendix A. 
CNSVS.  As described in detail above, the CNSVS is a computerized testing 
battery comprised of abbreviated versions of seven commonly used neurocognitive tests 
that takes about 30 minutes to complete (Gualtieri and Johnson, 2006a).  The tasks 
include verbal memory, visual memory, finger tapping, symbol-digit coding, the Stroop 
Test, shifting attention, and a CPT.  These tests tap a range of cognitive functions such as 
memory, reaction time, and attention.  Participants are guided through the tasks with 
comprehensive on-screen instructions and practice elements on more difficult tasks.  
Gualtieri and Johnson (2006a), the authors, propose that these domains are sensitive to 
detecting mild cognitive impairment.   
Gualtieri and Johnson (2006a) report test-retest reliability and concurrent validity 
data for the CNSVS.  On the individual subtests of the CNSVS, reliability coefficients 
range from .31 (Stroop errors) to .88 (CPT reaction time).  The authors measured 
concurrent validity by comparing performance on the CNSVS tasks to that on other 
empirically-supported tests measuring memory, psychomotor speed, executive 
functioning, and attention.  A range of correlation coefficients were found for memory 
(0.07-0.95), psychomotor speed (0.19-0.74), executive functioning (0.3-0.66), and 
attention (0.06-0.94), suggesting that, generally speaking, the CNSVS  taps constructs 
similar to those measured by conceptually related instruments.            
Procedures 
 Participants attended a single, group data collection session (i.e., baseline) in the 
morning after having fasted since midnight.  The full, treatment-study protocol involved a 
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physical evaluation including having their blood drawn before participants proceeded to a 
computer lab where they were given verbal instructions concerning the CNSVS.  
Subsequent completion of the CNSVS generally took about 20-30 minutes, as expected.  
All participants completed a paper version of the BSI the same day.  The ADHD survey 
was taken online within the week prior to the baseline data collection, with some 
participants completing it at a computer station at baseline.  The study adhered to 
American Psychological Association (APA, 2002) ethical guidelines.  The study received 
approval from the institutional review board of Appalachian State University on April 27, 
2009. 
Analyses 
 CNSVS raw scores were used in all analyses.  First, a Multivariate Analysis of 
Variance (MANOVA) examining potential between group differences across the seven 
CNSVS subtests (dependent variables) was conducted.  Follow up Analysis of Variance 
(ANOVA) procedures were conducted to further explore overall group differences on 
each of the CNSVS subtests.  Tukey post-hoc tests were conducted to examine pairwise 
differences between each group on the individual CNSVS subtest variables.  These 
comparisons included: ADHD-IA/ADHD-HI, ADHD-IA/CCD, ADHD-IA/CCA, 
ADHD-IA/Control, ADHD-HI/CCD, ADHD-HI/CCA, ADHD-HI/Control, CCD/CCA, 
CCD/Control, and CCA/Control.  Each Tukey test compared the differences between two 
means to determine whether the difference is statistically significant.  Finally, effect sizes 
for group differences were calculated to illustrate their practical significance, employing 
Cohen’s d.  Correlations were also run to demonstrate how individual ADHD traits are 
associated with the subtests of the CNSVS.   
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Results 
Demographic Analyses.  In order to document whether the comparison groups 
differed, demographically, age and education level were used as dependent variables in 
cross-group ANOVA analyses, and gender was similarly examined in a chi-square 
analysis.  Comparison groups did not differ by age, F (3, 699) = 0.52, p = .67.  They did, 
however, differ by level of education, F (3, 699) = 2.67, p < .05.  Tukey post-hoc 
comparisons show that education level of participants significantly differed only between 
the CCA and CCD group, however, p < .05, d = 0.7.  Individuals in the CCA group 
tended to have more education than did individuals in the CCD group.  Groups also 
differed according to gender, χ2 (1, N =700) = 16.79, p < .01.  Head to head group 
differences in terms of gender are as follows: ADHD-U and CCA χ2 (1, N = 87) = 3.32, p 
= .07, ADHD-U and CCD χ2 (1, N = 77) = 6.87, p < .01, ADHD-U and Control χ2 (1, N = 
652) = 36.79, p < .01, CCA and CCD χ2 (1, N = 50) = 3.92, p < .01, CCA and Control χ2 
(1, N = 624) = 21.97, p < .01, CCD and Control χ2 (1, N = 613) = 6.87, p < .01.  The 
ADHD-U group had the smallest proportion of male participants (27.87%).  The CCA 
group had the highest percentage of males (66.67%), while the CCD group and Control 
groups measured at 60% and 39.29%, respectively.  
Primary Analysis. An initial MANOVA was conducted to determine if group 
differences existed between the five groups (ADHD-IA, ADHD-HI/C, CCD, CCA, and 
non-diagnosed peers, hereafter described as Control).  The following variables were 
included in the MANOVA: Verbal Memory comprehensive score, Visual Memory 
comprehensive score, Right Finger Tapping average (number of taps), Left Finger 
Tapping average, Symbol Digit Coding Correct Responses, Stroop Simple Reaction Time, 
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Stroop Complex Correct Responses, Stroop Complex Commission Errors, Stroop Correct 
Responses, Stroop Reaction Time for Correct Response, Stroop Commission Errors, 
Shifting Attention Correct Responses, Shifting Attention Errors, Shifting Attention 
Reaction Time for Correct Responses, CPT Correct Responses, CPT Omission Errors, 
CPT Commission Errors, and CPT Reaction Time for Correct Responses.  This omnibus 
MANOVA did not return a statistically significant result, Wilks’ Lambda, Λ = .907, F (4, 
699) = .974, p = .538. 
A follow up MANOVA was conducted to determine if the two ADHD groups 
differed significantly, using the same outcome variables as noted above.  The overall 
MANOVA was not significant, Λ = .827, F (1, 59) = .529, p = .923.  Given that the two 
ADHD groups did not differ, they were combined into one group (ADHD-U) for 
subsequent analyses. A second, omnibus MANOVA was conducted to examine whether 
differences existed between the larger, undifferentiated ADHD group (ADHD-U), CCD, 
CCA, and the Control group.  Again, the MANOVA was not significant, Λ = .907, F (3, 
699) = 1.2, p = .13.  Though this result does not approach statistical significance, it 
appears to suggest that the added statistical power of a larger ADHD group helped to 
signal that potential group differences may exist that are of smaller magnitude, and that 
cannot be statistically detected in the current sample.  Cohen (1992), in fact, indicates 
that to achieve a statistical power of .80 for detecting “small” group differences using a 
four-group ANOVA, with alpha set at the traditional threshold (i.e., .05), one would need 
comparison groups of 274 or more participants-- obviously much larger than the ADHD-
U cell size.  Means and standard deviations including the ADHD-U group are provided in 
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Table 2.  Means and standard deviations by gender including the ADHD-IA, ADHD-HI, 
and ADHD-U groups are provided in Table 3. 
ANOVAs were conducted across all groups for each dependent variable.  A 
significant difference was found for Verbal Memory, F (3, 699) = 3.011, p = .03.  There 
were no other statistically significant or trend level (p < .1) differences across the CNSVS 
subtests.  See Table 4 for more detail regarding these ANOVA results. 
Pairwise Comparisons. As noted above, planned Tukey post-hoc comparisons 
were made across all groups on variables for which group differences (at the typical or 
trend levels) were detected.  For Verbal Memory, a trend towards significant differences 
(i.e., .1 > p > .05) was found between ADHD-U and CCA, p = .058, d = 0.52, and 
ADHD-U and CCD, p = .08, d = 0.6.  The ADHD-U group actually performed better on 
this task than the other three groups.   
No other significant or trend level differences were found. Effect size differences 
between ADHD-U and the three comparison groups on all dependent variables are listed 
in Table 5.        
Correlational Analysis: Inattention and Hyperactivity-Impulsivity and CNSVS Scores 
 A correlational analysis was conducted to examine the association between 
ADHD symptom clusters (Inattention, Hyperactivity/Impulsivity), in general, and the 
CNSVS subtests.  A trend towards significance was found between Inattention and 
Verbal Memory, r (702) = .071, p = .06.  
Significant correlations were also found between Hyperactivity/Impulsivity and 
Verbal Memory, r (702) =. 09,  p = .01, Visual Memory , r (702) = .127,  p = .001, 
Symbol Digit Coding Correct Responses , r (702) = .163,  p < .001, Stroop Reaction 
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Time for Correct Responses , r (700) = -.09,  p = .018, Shifting Attention Correct 
Answers, r (702) = -.08,  p = .05, and Shifting Attention Errors, r (702) = -.08,  p = .038.  
Further, a trend toward significance was found between Hyperactivity/Impulsivity and 
Stroop Correct Responses, r (700) = .07, p = .08, and Stroop Commission Errors, r (702) 
= -.068, p = .07.  A list of correlations between ADHD symptom clusters and all CNSVS 
variables is provided in Table 6.       
Exploratory Analysis: ADHD Effects in Younger Adult Subsample 
Given that differences between individuals with ADHD and others may gradually 
dissipate and become less evident with age (Mannuzza et al., 1993, 1998), further 
analysis was conducted with an age restricted sample.  Cases were restricted to 
individuals age 40 and under, corresponding to the recruitment demarcation for “young” 
adulthood in this sample.  This age cutoff was chosen because it corresponds to age-norm 
categories utilized with the measure of current ADHD symptomatology in this study 
(Barkley & Murphy, 2006).  A post-hoc MANOVA was conducted to determine 
differences between the four groups (ADHD-U n = 24, CDA n = 11, CDD n = 8, Control 
n = 215). Results show a trend towards significance, Λ = .767, F (3, 256) = 1.295, p 
= .086.  Tukey post hoc analysis showed significant differences on Stroop simple reaction 
time between the ADHD-U (M = 330.42, SD = 112.43) and CCA (M =272.27, SD = 19.4; 
p = .034) and control groups (M = 278.48, SD = 51.38; p < .001; CCD M = 273.68, SD = 
37.75).  A trend towards significance was found on Stroop simple reaction time between 
the ADHD-U group and CCD; p = .09.    
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   Exploratory Analysis: Effects in a Group with Clinical-level Childhood ADHD  
In order to create a more stringently “clinical” ADHD group—with elevated 
symptoms dating back to childhood—an exploratory MANOVA analysis was conducted 
with the ADHD-U group restricted such that individuals had to report not only significant 
adult symptoms and related impairment, but also clinically significant childhood ADHD 
symptoms.  The threshold for child impairment was based on Barkley and Murphy’s 
(2006) 1.5 standard deviation cutoff for ADHD symptom prevalence (elevation on either 
the HI or IA scales).  This procedure identified 15 participants (25%) from the ADHD-U 
group who reported more persistent ADHD symptoms.  The results of this analysis were 
not statistically significant, Λ = .922, F (3, 654) = .947, p = .58.  See Table 7 for means 
and standard deviations for both exploratory analyses. 
Discussion 
 
Summary of Findings  
 Contrary to the initial hypothesis, adults identified with clinically elevated 
ADHD symptoms did not show neurocognitive deficits, relative to a non-diagnosed 
control group, according to the CNSVS.  In fact, individuals did not meaningfully differ 
across the ADHD-U, CCD, CCA, and control groups.  Only the Verbal Memory task 
differentiated between the ADHD-U and other groups.            
  Somewhat surprisingly, the ADHD-U group performed better than the CCD and 
CCA groups on the Verbal Memory task.  In fact, many of the differences between the 
ADHD-U and comparison groups were not in the expected direction.  Participants from 
the ADHD-U group actually performed better than the CCA, CCD, and control groups on 
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subtests for Finger Tapping, Symbol Digit Coding, the Stroop tasks, the Shifting 
Attention task, and the CPT.     
There was little relation between the CNSVS and symptoms of Inattention and 
Hyperactivity/Impulsivity.  Though several of the CNSVS variables significantly 
correlate with Inattentive and Hyperactive/Impulsive symptoms, the strength of these 
associations is small.  It appears that only a small portion of the variance in CNSVS 
scores is related to the variance in ADHD symptoms, in this sample.    
Two post hoc analyses were conducted to explore whether the CNSVS might be a 
more sensitive ADHD indicator in selected subsamples.  First, all groups were restricted 
to only include individuals who were 40 years of age or younger.  Theoretically, 
restricting the age range could have increased the ability of the CNSVS to detect group 
differences, as some ADHD symptoms are thought to decrease with age (Mannuzza et al., 
1993, 1998).  This analysis did show a trend towards statistical significance (.05 < p < .1).  
Further analyses showed the ADHD-U group to differ from the CCA and control groups.  
Significant differences were found on Stroop simple reaction time, and a nearly 
significant difference was found between the ADHD-U group and the CCD group on this 
variable.  The ADHD-U group tended to perform worse on this task, which suggests that 
it may be useful for distinguishing individuals with ADHD in young adulthood.   A 
second post hoc analysis was conducted in which the total ADHD-U group was restricted 
to individuals reporting clinically-elevated current and childhood symptoms, meeting a 
stricter diagnostic threshold which, again theoretically, could have increased the 
likelihood for the CNSVS subtests to differentiate the groups.  However, no significant 
differences between groups were found in this analysis. 
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Differences from Gualtieri and Johnson’s Research 
 Understanding the failure to find differences between individuals identified with 
highly elevated ADHD traits (i.e., at minimum, a high risk for clinical diagnosis) and 
non-symptomatic and clinical control groups first necessitates a careful consideration of 
the differences between the current study and those conducted by Gualtieri and Johnson 
(2006a, 2006b) that established the initial CNSVS norms and its putative utility at 
identifying cases of ADHD. 
Sample size and power. Significant differences in performance may have been 
found between the ADHD-U group and the other groups had the ADHD-U group been 
larger.  Indeed, Gualtieri and Johnson (2006b) used an ADHD group composed of 175 
participants, while our sample included just 61 participants.  This is not an unusual 
limitation in the related literature; in fact, Barkley (2006) identifies small sample size as a 
common shortcoming amongst studies examining the neurocognitive functioning of 
adults with ADHD.  Effect sizes for group differences noted for CNSVS variables in 
Gualtieri and Johnson (2006b) ranged from .24 (small) to .52 (moderate). In the current 
study, there are actually fifteen pairwise effect sizes—in comparisons between the 
ADHD-U and clinical control groups that could theoretically aid in differentiating ADHD 
from other conditions in adulthood-- that fall into this range, yet none were statistically 
significant.  The fact that this study demonstrated some similar effect sizes on non-
significant pairwise comparisons, as compared to Gualtieri and Johnson (2006b), 
suggests that the cell sizes here resulted in suboptimal power.   
Power analyses conducted with G*Power 3.1 software (Faul, Erdfelder, Buchner, 
& Lang, 2009) indicated that with power set at 0.95 and an alpha (α) level of 0.05 the 
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necessary sample size required to detect moderate effects (f 2 = .15) on the initial 
MANOVA was 100 for each group, and that follow-up pairwise (t) analyses would need 
88 participants for each group to detect differences of a similar magnitude (d = .5).  
Power is unfortunately less than optimal for almost all analyses reported herein.  In fact, 
for the detection of moderately sized differences between the ADHD-U (n = 61) and the 
CCA (n = 21) groups, α would need to be set at 0.26 to achieve a power of 0.8.  Similarly, 
an α level of 0.16 is necessary for the same power in comparisons between the ADHD-U 
group and the CCD (n = 31).  Finally, to, again, detect moderate pairwise differences, an 
α level of 0.004 is required to achieve a power level of 0.8 given samples sizes for the 
ADHD-U group and the control group (n = 589).  Comparisons between the ADHD-U 
group and the control group may then have adequate power to find statistical differences 
with moderate effect sizes.  Unfortunately, several group effects from Gualtieri and 
Johnson (2006b) were in the small range, and to achieve a power of 0.8 to detect such 
differences, even between the ADHD-U and control group, α must be set at 0.5 or higher, 
which seems an unacceptable compromise for empirical research.               
Diagnostic Procedures. Participants in the Gualtieri and Johnson (2006b) study 
were compiled from case files for children, adolescents, and young adults who underwent 
a full psychological evaluation at the North Carolina Neuropsychiatry Clinic.  All 
participants underwent an administration of the CNSVS as part of the evaluation and 
received a primary diagnosis of ADHD.  Diagnoses were made by experienced clinicians 
based on DSM-IV-TR criteria.  All cases were reviewed by a senior psychiatrist as well.  
Individuals with comorbid disorders were excluded from the sample.  Conversely, those 
assigned to our ADHD-U group were identified only via self-report measures, and 
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participants reporting significant symptoms of depression and anxiety were not excluded.  
Consequently, these less-stringent inclusion criteria may have resulted in false positive 
inclusions in the ADHD-U group, which may have diminished the group’s mean 
cognitive impairment (i.e., executive dysfunction) and thereby limited the ability to find 
expected differences on the CNSVS subtests.   
Evidence exists to suggest this may, indeed, be a valid criticism. Some 
community-based research suggests that “normal” adults often report having significant 
levels of ADHD symptoms at some time in their life.  In a sample of 719 non-diagnosed 
adults, Murphy, Gordon, and Barkley (2002) reported that a large majority of individuals 
reported at least six symptoms of ADHD occurring “at least sometimes” in both 
childhood (80%) and adulthood (75%).  Further, 25% of their sample reported a similar 
quantity of symptoms as occurring “often or very often” in childhood, while 12% of the 
sample reported symptoms as occurring “often or very often” in adulthood.  Given that 
prevalence estimates for ADHD are much lower in childhood and adulthood, there may 
be a tendency for adults to over report symptoms of ADHD.  However, our ADHD-U 
group is approximately 6% of the sample, which is in line with the expected base rate of 
ADHD in adulthood (Kessler et al., 2006) and seems, at least on the surface, to suggest 
that we did not egregiously over-classify participants into ADHD groups. 
On another tack, of the participants in the ADHD-U group, 18 (29.5%) reported 
elevated levels of anxiety and depression, 8 (13.1%) reported elevated levels of anxiety, 
and 7 (11.5%) reported elevated levels of depression.  In all, 33 (54%) participants in the 
ADHD-U group reported comorbid anxiety, depression, or both.  This is not necessarily 
unexpected given comorbidity estimates from epidemiological research.  For instance, in 
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a large-scale study with participants representative of the United States as a whole 
Kessler and colleagues (2006) found that 18.6% of individuals identified with ADHD 
were also identified as having major depressive disorder, and 47.1% met criteria for an 
anxiety disorder.  Nevertheless, inclusion of participants with co-occurring symptoms of 
anxiety and depression into the ADHD-U group may have somewhat hindered the 
CNSVS’s ability to distinguish performance across the three clinical groups, as compared 
to the “pure” ADHD sample employed by Gualtieri and Johnson (2006a, 2006b).    
Age Range. The normative study for the CNSVS by Gualtieri and Johnson (2006a) 
included ADHD groups with a mean age near thirteen years.  The other Gualtieri and 
Johnson (2006b) study included slightly older participants, typically in their late teens (M 
age = 18.5 years).  On the other hand, our sample included adults of all ages, with those 
in the ADHD group averaging right around forty-five years of age.  This must, of course, 
be taken into consideration when interpreting the current findings, given that converging 
evidence suggests that ADHD symptoms ameliorate as individuals develop in adulthood.  
For instance, in two separate cohorts, research has shown that only 31% and 43% of 
hyperactive children continued to be significantly impaired in early adulthood (mean age 
= 18.5 years; Gittelman et al., 1985; Mannuzza et al., 1991), as measured with a 
structured interview using DSM-III criteria.  Eight years later—and while probands were 
still by and large in their twenties—follow-up established that those meeting impairment 
criteria for hyperactivity fell to 8% and 4% respectively (mean age = 26 years; Mannuzza 
et al., 1993, 1998).  
More recent research has shown that such findings likely underestimate the 
persistence of ADHD in adulthood.  As cited earlier, Barkley and colleagues (2002) 
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found that 66% of children with ADHD were also diagnosed in adulthood, and their 
findings may be more accurate as they used developmentally referenced criteria to 
identify ADHD.  Still other researchers have derived mixed findings regarding age 
effects. For instance, Fischer and colleagues (2005) found that hyperactive children who 
still had a diagnosis of ADHD in young adulthood did continue to show deficits in 
executive functioning when compared to controls, although improvement in attention and 
inhibition was seen across groups.   
While the evidence, therefore, is somewhat ambiguous with regard to how 
persistent ADHD symptoms tend to be beyond adolescence, it is important to note that 
virtually all of the “long-term” follow-up research on ADHD has really only measured 
the persistence of ADHD symptoms into early, or, at most, middle adulthood, and little is 
known concerning the persistence of symptoms further along the lifespan.  Hyperactive 
symptoms may, in fact, continue to normalize over time, and related impairment in 
neurocognitive functioning may also subside.  The inattention that is obvious in some 
individuals with ADHD at younger ages could possibly ameliorate in later life, as well, in 
comparison to non-diagnosed age-mates.  Simply put, there may only be very small and 
difficult-to-detect differences that discriminate between those with ADHD and those 
without, by mid- or late adulthood.     
A limitation, however, of the existent literature is that research examining such 
symptom amelioration has focused primarily on hyperactivity.  Inattentive symptoms are 
more likely to persist into adulthood (Spencer, Biederman, & Mick, 2007).  Nigg and 
colleagues (2005) suggest that individuals with ADHD-IA should show more deficits in 
executive functioning than should individuals with the hyperactive type.  Extrapolating 
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from Nigg’s assertion as well as evidence that the IA and HI symptom clusters’ 
persistence varies across time, one would expect that the CNSVS subtests would 
distinguish between the ADHD-IA and ADHD-HI groups in an adult sample.  However, 
this was not the case.  Whether or not ADHD subtypes actually do continue to differ in 
neurocognitive impairment in adulthood will be discussed in more detail later.        
 Medication. To determine if treatment altered the performance of the ADHD-U 
group, current self-reported medication usage was informally examined, post hoc.  Only 
four individuals in the ADHD-U group self-reported being currently on an ADHD 
medication on an open-ended question regarding general, current pharmacological 
treatments; to the extent that this one-item, face valid measure of current usage tapped the 
possibility of ADHD medication effects in this sample, ongoing treatment seems a quite 
unlikely explanation for the better performance of the ADHD-U group, relative to 
Gualtieri and Johnson’s (2006b) sample.  
Educational Attainment 
The high level of educational attainment for individuals in the ADHD-U group 
represents a unique characteristic of this community sample.  Barkley (2006) points out 
individuals with ADHD tend to obtain less education than do control groups.  In one 
sample, Barkley (2006) notes, 32% of individuals identified as being hyperactive did not 
finish high school.  Further, only 21% of this hyperactive group enrolled in college, as 
compared to 78% of the control group.  In another study of young adults with ADHD, it 
was again found that the ADHD groups had significantly less education;  only 6.3% of 
participants in the ADHD-IA group graduated from college, while 7.3% of participants in 
the ADHD Combined type graduated from college (Murphy et al., 2002).  The ADHD-U 
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group included 36 participants (59%) who reported completing 4 or more years of college, 
which stands in stark contrast to this trend of educational underachievement.   
Consequently, it seems likely that the participants identified in the ADHD-U 
group are “high functioning”—or even sub-clinical-- relative to other individuals with 
ADHD.  Indeed, individuals in the ADHD-U group actually performed significantly 
better on the CNSVS Verbal Memory task than the CCD and CCA groups, and 
indistinguishably from the non-clinical control group. This unexpectedly high level of 
educational attainment and cognitive functioning in the ADHD-U group may be in part 
due to the nature of the community from which the sample was taken.  Boone, North 
Carolina, is a small college town with many of its residents associated with Appalachian 
State University and other organizations that provide professional services to the 
surrounding rural area (e.g., hospital, county-level governance, law offices).  Many 
individuals across the comparison groups have achieved high levels of education, and this 
likely represents a bias toward high intellectual ability in this community sample. 
Differences in executive functioning between individuals with ADHD and other groups 
may have been more difficult to detect due to this trend.        
Testing Protocol 
The CNSVS test protocol calls for individual administration.  However, due to the 
size of the testing group and relatively limited administration time, we administered the 
CNSVS in a group format, utilizing a computer lab to test up to about 30 participants at a 
time.  The seating in this environment was such that many individuals had a participant 
on both their left and their right, engaged in the same CNSVS battery but often 
completing a different subtest, concurrently.  In addition, as testing was implemented 
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continuously in this computer lab, the vast majority of the participants completed the 
CNSVS battery as others came or went.  Spacing was maintained as much as possible 
(e.g., every other computer used). While the CNSVS was designed to be taken without 
even a test administrator present, its administration in the current study represents a 
substantial deviation from test protocol, and  these environmental differences may have 
caused distraction and some added difficulty for participants.  Generally speaking, the 
influence of having multiple individuals in the testing environment—other participants 
and “helpful” research assistants, alike—may have diluted the sensitivity of the battery.  
Further, participants were in unique circumstances, nutritionally, as they had fasted the 
entire morning and had undergone a physical evaluation prior to administration of the 
CNSVS.  Perhaps this could have had a sort of leveling affect, as low energy might have 
contributed to inattention or sluggishness across groups.  In any event, these 
circumstances deviate from standard protocol and should certainly be weighed when 
interpreting the data. 
 Though there is no published research that has specifically examined how group 
administration of a computer-based, neurocognitive testing battery designed for 
individual usage effects outcome scores, there is ample evidence suggesting that mode of 
administration and social environment does affect task and test performance, in general.  
In a study examining such factors, Whitener and Klein (1995) found that measures of self 
esteem were significantly affected by whether they were administered in group or 
individual settings.  While self-esteem questionnaires have little in common with 
neurocognitive testing batteries, it still seems plausible that performance on the CNSVS 
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in the current study may have been altered, as compared to that of Gualtieri and 
Johnson’s (2006a, 2006b), simply via the experience of being in a group, as well.   
Research for standardized testing may provide more relevant comparisons.  Mode 
effects have been found in studies measuring computerized vs. pencil and paper test 
administrations.  Keng, McClarty, and Davis (2008) found that adolescents generally 
performed better on pencil and paper version compared to computerized versions of an 
aptitude test.  In measuring differences between neurocognitive testing modes for 
individuals with schizophrenia, O’Halloran and colleagues (2007) found that standard 
paper and pencil administrations and computerized administrations ranged in intraclass 
correlation between 0.61 and 0.95.  These findings suggest that altering test mode can, at 
least at times, produce significant variability in test performance.   
Another consideration involves the influence of external distracters in testing 
situations.  Tinius (2002) found that adults with ADHD (M age = 31.8 years) tended to 
have high variability in reaction time on the CPT.  The author concluded that adults with 
ADHD were susceptible to distraction from external stimuli.  Indeed, one might expect 
that increased external distracters would impair performance across groups.  However, 
there appears to be little difference between the mean performance across subtests when 
comparing the ADHD group employed by Gualtieri and Johnson (2006b) and the one 
identified for this study.  This suggests that there was not a systematic downward shift in 
performance across groups in the current study.  Further, while higher standard 
deviations in the sample might indicate increased situational distraction, our groups were 
equivalent to, and sometimes smaller than, those derived in Gualtieri and Johnson’s study 
(2006b). Overall, quantitative analysis of the testing results along these lines seems to 
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suggest that distraction due to the testing format, itself, may not have detracted 
meaningfully from the ability to detect ADHD-related differences in this study. 
Neurocognitive Deficits and ADHD 
 The current findings bring in to question whether or not the CNSVS, or 
neurocognitive test batteries in general, are sensitive to identifying adults with or at 
elevated risk for ADHD.  While neurocognitive testing is generally not viewed as 
appropriate for diagnosing ADHD (Seidman, 2006), much research suggests that 
individuals with ADHD do tend to perform worse on such measures (as noted previously; 
see Barkley, 2006, for an overview).  However, results from studies specific to adults 
have been mixed.   
Studies measuring differences between adults with ADHD and non-diagnosed 
peers using CPT tasks have been particularly inconclusive.  While several studies have 
shown adults with ADHD tend to perform more poorly on CPT tasks (Schoechlin, & 
Engel, 2005; Murphy, Barkley, & Bush, 2001; Barkley, Murphy, & Kwasnik, 1996), 
Preston and colleagues (2005) found that CPT variables did not distinguish between an 
ADHD group and individuals with subclinical ADHD symptoms.  McGee, Clark, and 
Symons (2000) questioned whether CPT tasks were more indicative of reading disorders 
rather than ADHD.  The authors found that a CPT could not discriminate between ADHD 
and Reading Disordered (RD) groups.  They also found that a measure of phonological 
awareness was statistically related to a CPT index score (albeit rather weakly, r = -.23).  
The current study also suggests, overall, that the CPT may provide poor discriminant 
validity for ADHD, at least in adulthood. 
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Contrary to research cited earlier which supports the use of the Shifting Attention 
task to distinguish ADHD from controls (e.g., Solanto et al., 2007; Jenkins et al., 1998), 
this measure may, in fact, not be appropriate for assessment of this population in 
adulthood.  The majority of the extant research on measures similar to the CNSVS 
Shifting Attention task has focused on the Wisconsin Card Sorting Task (WCST), which 
is thought to measure cognitive flexibility.  Frazier and colleagues (2004) conducted a 
meta-analysis of studies measuring differences on WCST performance between children 
with ADHD and non-diagnosed peers.  The authors found mean weighted effect size 
differences between groups to be 0.35 for perseveration scores, 0.29 for categorization 
(i.e., rule detection), and 0.15 for the number of set failures (i.e. failed to recognize a new 
set of task-oriented rules).  None of these effect sizes were statistically significant.  
Barkley (2006) concludes that the experience of ADHD is not likely to have an adverse 
affect on the cognitive function measures by the WCST.  Similarly, the Shifting Attention 
task of the CNSVS may represent a cognitive function that is not deficient in adults with 
ADHD. 
 There is also some question as to whether or not individuals with ADHD differ 
consistently from their non-ADHD peers in executive functioning.  Doyle, Biederman, 
Seidman, Weber, and Faraone (2000) found children with ADHD did perform worse than 
non-diagnosed peers on a testing battery including a Stroop task, a CPT, and the WCST.  
However, individuals within the ADHD group showed marked variation in terms of the 
extent of their individual deficits on these executive functioning and attention tasks.  To 
wit, some suggest that deficits in executive functioning are most profound in individuals 
with ADHD-IA (Sonuga-Barke, 2002).  Nigg and colleagues (2005) found that measures 
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of executive functioning were uniquely sensitive to identifying deficits in individuals 
with ADHD-IA, as opposed to those with prominent hyperactivity-impulsivity, who 
tended to register deficiencies more on measures of psychomotor speed.  Further, 
Seidman (2006) suggests that individuals primarily suffering from hyperactive-impulsive 
symptoms are more likely to exhibit impairment in brain reward systems that are 
independent of executive functioning.  The current study did not reveal any differences 
between the ADHD-IA and ADHD-HI groups.  The authors of the CNSVS (Gualtieri & 
Johnson, 2006a, 2006b) did not establish differences between these groups, per se, but 
findings from the current study underscore that this neurocognitive battery may not be 
sensitive to the unique deficits of the ADHD types.    
Implications of Exploratory Analyses 
 While creating more stringent standards for inclusion in the ADHD-U group 
should have derived a group that more closely resembled the clinical populations used by 
Gualtieri and Johnson (2006a, 2006b), analyses still mostly resulted in null findings, with 
the only exception being Stroop simple reaction time.  Low power can partially explain 
this finding, as the ADHD-U group was reduced to a mere 25% of its original size.  
However, the overall MANOVA did not even approach trend level significance, which 
fits with other data presented here that suggests that neurocognitive differences between 
individuals with ADHD and other groups may not be robust in middle and older 
adulthood—or, at the least, that the CNSVS battery is not sensitive enough to detect them. 
  Given that neurocognitive deficits have been shown for individuals with ADHD 
into young adulthood, it was hypothesized, post-hoc, that the CNSVS would be better 
able to distinguish the age-restricted ADHD-U group from the other groups.  While a 
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trend toward statistical significance was found in this exploratory analysis, further 
examination showed that differences on Stroop simple reaction time drove this difference 
and were, in fact, not in the expected direction.  As noted previously, this may be a 
consequence of the relatively high functioning of the ADHD-U group used in these 
analyses.  In addition, as in the previous exploratory analysis, the sample size was 
significantly reduced, which may have decreased the power to detect smaller differences 
that would be more in line with expectations (i.e., signaling impairment in the ADHD-U 
group relative to others).  Further, Gualtieri and Johnson (2006b) identified young 
adulthood as being ages 20-29 years, as compared to the 40-or-below criterion employed 
herein.  Still, the age-restricted analysis suggests that, even before middle age, the 
CNSVS may not differentiate ADHD from other groups.   
Limitations and Future Directions 
Much of the preceding discussion has focused on limitations and qualifications 
regarding the current study and interpretation of its findings.  However, it is important to 
highlight the most salient of these, for clarity’s sake.  First, self report measures alone are 
not ideal in identifying ADHD.  A full psychological evaluation may have allowed for 
more accurate assignment to groups.  One piece of evidence that suggests that diagnostic 
uncertainty exists herein, given the criteria we used to identify “ADHD” participants, is 
that when childhood symptoms were taken into consideration—a requirement for strict 
DSM-IV-TR diagnosis—the ADHD-U group decreased to just a quarter of its original size.  
This indicates that some of our identified ADHD group participants either do not meet 
full diagnostic criteria for ADHD, do not accurately recall the extent of their childhood 
symptoms, currently exhibit ADHD symptoms that are extensive but due to another, non-
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neurological cause, or a combination thereof.  Given this likely degree of heterogeneity 
and resulting “subclinical” or even false-positive “ADHD” cases, detection of “true” 
group differences was likely made more difficult.  
Second, Gualtieri and Johnson (2006a, 2006b) used samples ranging from 
childhood to young adulthood.  Our study used a sample of individuals ranging across the 
adult lifespan, and this difference does not lend easily to direct comparison of results.  
Third, as noted above, although the sample as a whole was quite large, its community-
derived nature equated to relatively few individuals with ADHD traits that are clinically 
elevated.  The consequence: Low statistical power that limits of the ability to detect 
differences between the ADHD-U and other groups. Perhaps a larger sample size would 
allow for the detection of differences that are smaller in effect size. However, as stated 
earlier, Cohen (1992) suggests clinical group cell sizes would need to be substantially 
larger to achieve statistical significance in F tests, given the effect sizes in the current 
study.   
Fourth, the demographic composition of the sample differs significantly from that 
of both the general U.S. population and that of the larger group of individuals with 
ADHD.  For instance, educational attainment amongst the ADHD-U group is far better 
than what would be expected in a community sample of individuals with ADHD.  Higher 
attainment of education may indicate that our ADHD group is high functioning relative to 
most in that population.  Furthermore, the ethnic distribution in this sample is far from 
diverse.  Consequently, for these and other reasons (e.g., doubts regarding the “clinical” 
nature of ADHD-identified individuals), generalization of these findings to the 
population of ADHD individuals should be done only with great caution. 
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Clinical Implications. The current study suggests several important implications 
regarding ADHD in adulthood.  First, contrary to previous studies examining 
neurocognitive deficits in younger populations, the CNSVS did not differentiate subtypes 
of ADHD in adulthood.  Perhaps subtype classifications become less meaningful, from a 
cognitive functioning perspective, as those with ADHD progress through adulthood.  
Future research examining the nature of symptom expression specific to adults with 
ADHD would be helpful.     
Interestingly and despite the preponderance of null findings in the study, medium 
effect sizes between the ADHD-U group and the CCA and CCD groups were found for 
several CNSVS subtests.  These subtests include both Verbal and Visual memory, Finger 
tapping, Shifting attention and several Stroop tasks.  Future studies with  large samples of 
rigorously identified adults with attention-deficit, mood, and anxiety disorders may 
productively include this brief CNSVS battery in their study protocol to enable a targeted 
examination of whether a subset of CNSVS tests has some clinical utility for 
differentiating these conditions.       
Finally, the current study underscores the considerable challenge of diagnosing 
ADHD in adulthood.  Diagnostic criteria require that ADHD symptoms be present in 
childhood.  For individuals who present for psychological evaluation in adulthood, 
obtaining and substantiating such information is often difficult.  Further adding to these 
difficulties is the relatively unknown course of ADHD throughout the lifespan.  One may 
expect that neurocognitive deficits that have been found in younger individuals with 
ADHD would persist throughout adulthood, and therefore provide a robust indicator of 
chronic psychological disorder.  However, there is not a great deal of research supporting 
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this contention.  The current study suggests that neurocognitive deficits may not persist-- 
at least in “higher-functioning” cases, or precisely those that might present in adulthood 
for diagnosis-- further disrupting the ability to identify ADHD in adulthood. 
Conclusions.  Neurocognitive testing batteries have been shown to be sensitive to 
identifying deficits in children, adolescents, and, to an extent, young adults with ADHD.    
However, more research on neurocognitive functioning across the lifespan is necessary. 
Research examining neurocognitive deficits in ADHD is especially lacking for those over 
the age of 40.  Given that ADHD symptom experience may not be consistent across the 
lifespan, performance on neurocognitive batteries may also vary as individuals age.  
Results from the current study suggest that the CNSVS may not be useful in 
distinguishing adults with ADHD.  Longitudinal research, which follows children 
diagnosed with ADHD across the lifespan, may provide further understanding into the 
sensitivity of neurocognitive measures, including the CNSVS.   
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Table 1 
Means and Standard Deviations for Demographic Variables across Groups 
 
 ADHD-IA 
(n = 34) 
ADHD-HI 
(n = 27) 
CCA 
(n = 21) 
CCD 
(n = 31) 
Control 
(n = 589) 
Age 45.67 
(14.69) 
45.89 
(13.87) 
45.27 
(13.96) 
42.7 
(16.63) 
46.01 
(16.81) 
Education in 
Years 
16.03 
(2.79) 
16.12 
(2.37) 
15.97 
(2.43) 
14.45 
(2.93) 
15.71 
(2.71) 
Gender (% 
Male) 
38.24% 14.8% 66.67% 60% 39.29% 
Inattention  13.91 
(2.77) 
13.42 
(5.13) 
7.1 
(3.84) 
6.2 
(3.14) 
3.63 
(2.94) 
Hyperactivity- 
Impulsivity 
8.58 
(2.62) 
14.43 
(4.64) 
5.93 
(3.47) 
6.6 
(3.8) 
3.87 
(3.07) 
BSI Anx. 
Scale Score 
63.97 
(9.76) 
59.04 
(10.7) 
67.57 
(3.2) 
54.35 
(8.42) 
47.21 
(7.13) 
BSI Dep. 
Scale Score 
61.36 
(12.15) 
60.52 
(8.67) 
53.9 
(5.63) 
66.55 
(5.25) 
46.26 
(8.07) 
Note. ADHD-IA = ADHD Inattentive group, ADHD-HI = ADHD Hyperactive/Impulsive 
or Combined type group, CCD = Depression Clinical Comparison group, CCA= Anxiety 
Clinical Comparison group.   ADHD symptoms based on current self symptom reports 
(Barkley and Murphy, 2006).  BSI Anx. = BSI Anxiety, BSI Dep. = BSI Depression.  
BSI Scale scores measure current Depressive and Anxious symptoms (Derogatis, 199). 
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Table 2 
Means and Standard Deviations for CNSVS across Groups 
 
Dependent 
Variable 
ADHD-U 
(n = 61) 
Anxiety 
(n = 21) 
Depression 
(n = 31) 
Control 
(n = 589) 
ADHD-GJ 
(n = 175) 
Verbal Memory 
 
53.7 
 (4.94) 
51 
(5.36) 
50.75 
(4.91) 
52.61 
(4.83) 
51.62  
(5.69) 
Visual Memory 
 
45.82 
(5.23) 
44.83 
(5.99) 
44.25 
(5.19) 
45.8 
(5.22) 
46.73  
(5.85) 
FT Right 
 
56.9 
(10.96) 
60.72 
(7.5) 
59.27 
(8.36) 
58.28 
(9.03) 
-- 
FT Left 
 
55.19 
(7.84) 
57.91 
(6.7) 
55.77 
(9.16) 
55.11 
(8.05) 
-- 
SDC Correct 
 
53.61 
(13.69) 
55.03 
(13.14) 
49.7 
(17.98) 
53.92 
(14.02) 
54.17 
(13.48) 
Stroop Simple 
RT 
318.98 
(110.12) 
279.33 
(32.99) 
293.55 
(74.56) 
303.98 
(75.09) 
314.37 
(119.75) 
Stroop Complex 
Corr. 
11.9 
(0.35) 
11.97 
(0.18) 
12.00 
(0.00) 
11.82 
(1.19) 
-- 
Stroop Complx. 
Com.  
0.3 
(0.62) 
0.27 
(0.52) 
0.45 
(0.61) 
0.38 
(0.75) 
-- 
Stroop Correct 
  
23.46 
(2.75) 
23.6 
(1.13) 
23.9 
(0.3) 
23.42 
(2.92) 
-- 
Stroop RT 710.26 695.3 686.2 699.08 -- 
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Correct (149.75) (122.41) (119.82) (137.38) 
Stroop Com. 
Errors 
1.31 
(1.54) 
2.1 
(2.83) 
1.65 
(1.18) 
1.7 
(2.44) 
-- 
SAT Correct 
 
48.31 
(10.48) 
53.37 
(8.2) 
50.35 
(10.8) 
49.68 
(10.97) 
46.19 
(10.18) 
SAT Errors 
 
6.43 
(6.05) 
5.17 
(6.68) 
6.75 
(4.99) 
7.07 
(8.02) 
12.43 
(11.38) 
SAT RT Correct 1143.39 
(161.33) 
1066.37 
(180.42) 
1116.63 
(198.81) 
1084.29 
(209.21) 
-- 
CPT Correct 
 
39.33 
(3.25) 
39.63 
(1.33) 
39.45 
(1.28) 
39.2 
(4.45) 
38.9  
(2.24) 
CPT Omission 
Errors 
0.67 
(3.25) 
0.37 
(1.3) 
0.55 
(1.28) 
0.52 
(3.01) 
-- 
CPT Comm. 
Errors 
1.93 
(12.01) 
4.57 
(21.19) 
0.85 
(1.63) 
1.95 
(11.63) 
-- 
CPT RT Correct 441.56 
(70.38) 
432.6 
(101.57) 
436.2 
(46.87) 
429.61 
(62.1) 
-- 
Note. FT Right = Right Finger Tapping average (number of taps), FT Left =Left Finger 
Tapping average, SDC Correct = Symbol Digit Coding Correct Responses, Stroop 
Simple RT = Stroop Simple Reaction Time, Stroop Complex Corr. = Stroop Complex 
Correct Responses, Stroop Complx. Com. = Stroop Complex Commission Errors, Stroop 
Correct = Stroop Correct Responses, Stroop RT Correct = Stroop Reaction Time for 
Correct Response, Stroop Com. Errors = Stroop Commission Errors, SAT Correct 
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= Shifting Attention Correct Responses, SAT Errors = Shifting Attention Errors, SAT RT 
Correct = Shifting Attention Reaction Time for Correct Responses, CPT Correct = CPT 
Correct Responses, CPT Omission Errors = CPT Omission Errors, CPT Comm. Errors = 
CPT Commission Errors, CPT RT Correct = CPT Reaction Time for Correct Responses, 
and ADHD-GJ = ADHD group data from Gualtieri and Johnson (2006b), where available. 
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Table 3 
Means and Standard Deviations for CNSVS across Gender for ADHD-IA, ADHD-HI, 
and ADHD-U groups  
 ADHD-
IA Male 
ADHD-
IA Fem. 
ADHD-
HI Male 
ADHD-
HI Fem. 
ADHD-
U Male 
ADHD-
U Fem. 
Verbal Memory 52.23 
(5.56) 
53.4 
(5.73) 
53.5 
(4.8) 
54.79 
(3.86) 
52.54 
(5.27) 
54.16 
(4.8) 
Visual Memory 45.77 
(6.41) 
45.55 
(5.58) 
46.75 
(0.5) 
45.92 
(4.91) 
46 
(5.57) 
45.75 
(5.16) 
Ft Right 56.13 
(13.67) 
57.68 
(8.87) 
61.75 
(6.23) 
55.85 
(11.81) 
57.45 
(12.39) 
56.68 
(10.5) 
Ft Left 57.08 
(6.62) 
54.15 
(6.92) 
58.17 
(3.05) 
54.53 
(9.58) 
57.33 
(5.9) 
54.36 
(8.39) 
SDC Correct 48.85 
(14.78) 
53.4 
(12.8) 
50.5 
(16.76) 
56.88 
(13.31) 
49.24 
(14.73) 
55.3 
(13.05) 
Stroop Simple RT 315.62 
(172.47) 
325.2 
(82.18) 
298.75 
(50.74) 
319 
(100.45) 
311.65 
(151.15) 
321.82 
(91.59) 
Stroop Complex 
Corr. 
11.92 
(0.28) 
11.9 
(0.31) 
12 
(0.00) 
11.88 
(0.45) 
11.94 
(0.24) 
11.89 
(0.39) 
Stroop Correct 23.54 
(1.13) 
22.9 
(4.69) 
24 
(0.00) 
23.79 
(0.66) 
23.65 
(0.99) 
23.39 
(3.19) 
Stroop RT Correct 774.85 
(219.53) 
680.75 
(79.43) 
697 
(126.99) 
702.08 
(151.09) 
634 
(156.63) 
607.57 
(81.98) 
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Stroop Com. Errors 0.23 
(0.44) 
0.15 
(0.49) 
0.5 
(0.58) 
0.42 
(0.78) 
1.41 
(1.06) 
1.27 
(1.7) 
SAT Correct 48.23 
(11.1) 
47.85 
(10.89) 
51 
(11.61) 
48.29 
(10.27) 
48.88 
(10.91) 
48.09 
(10.43) 
SAT Errors 6.46 
(7.52) 
6.9 
(6.71) 
4 
(2.58) 
6.42 
(5.17) 
5.88 
(6.7) 
6.64 
(5.86) 
SAT RT Correct 1146.19 
(162.85) 
1133.5 
(132.3) 
1174.33 
(243.74) 
1144.97 
(177.74) 
1152.81 
(176.58) 
1139.76 
(157.05) 
CPT Correct 39.77 
(0.44) 
39.9 
(0.31) 
40 
(0.00) 
38.5 
(5.12) 
39.82 
(0.39) 
39.14 
(3.81) 
CPT Omission 
Errors 
0.23 
(0.44) 
0.1 
(0.31) 
0 
(0.00) 
1.5 
(5.12) 
0.18 
(0.39) 
0.86 
(3.8) 
CPT Comm. Errors 0.31 
(0.63) 
0.2 
(0.41) 
0.25 
(0.5) 
4.54 
(19.09) 
0.29 
(0.59) 
2.57 
(14.13) 
CPT RT Correct 418.92 
(39.88) 
445.9 
(57.83) 
408 
(621.2) 
455.79 
(90.06) 
416.35 
(44.05) 
451.3 
(70.38) 
Note. Fem. = Female, FT Right = Right Finger Tapping average (number of taps), FT 
Left =Left Finger Tapping average, SDC Correct = Symbol Digit Coding Correct 
Responses, Stroop Simple RT = Stroop Simple Reaction Time, Stroop Complex Corr. = 
Stroop Complex Correct Responses, Stroop Complx. Com. = Stroop Complex 
Commission Errors, Stroop Correct = Stroop Correct Responses, Stroop RT Correct = 
Stroop Reaction Time for Correct Response, Stroop Com. Errors = Stroop Commission 
Errors, SAT Correct = Shifting Attention Correct Responses, SAT Errors = Shifting 
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Attention Errors, SAT RT Correct = Shifting Attention Reaction Time for Correct 
Responses, CPT Correct = CPT Correct Responses, CPT Omission Errors = CPT 
Omission Errors, CPT Comm. Errors = CPT Commission Errors, CPT RT Correct = CPT 
Reaction Time for Correct Responses. 
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Table 4 
 
Analysis of Variance Results: ADHD-U Comparisons 
 
Dependent Variable 
 
F value p value 
Verbal Memory 
 
3.01 0.03* 
Visual Memory 
 
0.89 0.45 
FT Right 
 
1.25 0.29 
FT Left 
 
1.25 0.29 
SDC Correct 
 
0.62 0.61 
Stroop Simple RT 
 
1.83 0.14 
Stroop Complex 
Correct 
0.38 0.77 
Stroop Complex 
Com. Errors 
0.57 0.64 
Stroop Correct 
  
0.22 0.88 
Stroop RT Correct 
 
0.18 0.91 
Stroop Com. Errors 
 
0.78 0.51 
SAT Correct 
 
1.52 0.21 
SAT Errors 
 
0.78 0.51 
SAT RT Correct 
 
1.77 0.15 
CPT Correct 
 
0.12 0.95 
CPT Omission 
Errors 
0.08 0.97 
CPT Comm. Errors 
 
0.52 0.67 
CPT RT Correct 
 
0.65 0.59 
Note. FT Right = Right Finger Tapping average (number of taps), FT Left =Left Finger 
Tapping average, SDC Correct = Symbol Digit Coding Correct Responses, Stroop 
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Simple RT = Stroop Simple Reaction Time, Stroop Complex Corr. = Stroop Complex 
Correct Responses, Stroop Complx. Com. Errors = Stroop Complex Commission Errors, 
Stroop Correct = Stroop Correct Responses, Stroop RT Correct = Stroop Reaction Time 
for Correct Response, Stroop Com. Errors = Stroop Commission Errors, SAT Correct 
= Shifting Attention Correct Responses, SAT Errors = Shifting Attention Errors, SAT RT 
Correct = Shifting Attention Reaction Time for Correct Responses, CPT Correct = CPT 
Correct Responses, CPT Omission Errors = CPT Omission Errors, CPT Comm. Errors = 
CPT Commission Errors, and CPT RT Correct = CPT Reaction Time for Correct 
Responses. 
* p < .05. 
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Table 5 
 
Effect Size Differences between ADHD-U and Other Groups (Cohen’s d) 
 
Dependent Variable Anxiety Depression Control 
Verbal Memory 
 
0.52† 0.6† 0.22 
Visual Memory 
 
0.18 0.3 0.01 
FT Right 
 
-0.41 -0.24 -0.14 
FT Left 
 
-0.37 -0.07 0.01 
SDC Correct 
 
-0.12 0.24 -0.02 
Stroop Simple RT 
 
0.49 0.27 0.16 
Stroop Complex 
Correct 
-0.25 -0.4 0.09 
Stroop Complex 
Com. Errors 
0.05 -0.24 -0.12 
Stroop Correct 
  
-0.07 -0.22 0.01 
Stroop RT Correct 
 
0.11 0.18 0.08 
Stroop Com. Errors 
 
-0.35 -0.25 -0.19 
SAT Correct 
 
-0.54 -0.19 -0.13 
SAT Errors 
 
0.19 0.2 -0.06 
SAT RT Correct 
 
0.45 0.15 0.32 
CPT Correct 
 
-0.12 -0.05 0.03 
CPT Omission 
Errors 
0.12 0.05 0.05 
CPT Comm. Errors 
 
-0.15 0.13 -0.01 
CPT RT Correct 
 
0.1 0.09 0.18 
Note. FT Right = Right Finger Tapping average (number of taps), FT Left =Left Finger 
Tapping average, SDC Correct = Symbol Digit Coding Correct Responses, Stroop 
Simple RT = Stroop Simple Reaction Time, Stroop Complex Corr. = Stroop Complex 
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Correct Responses, Stroop Complx. Com. Errors = Stroop Complex Commission Errors, 
Stroop Correct = Stroop Correct Responses, Stroop RT Correct = Stroop Reaction Time 
for Correct Response, Stroop Com. Errors = Stroop Commission Errors, SAT Correct 
= Shifting Attention Correct Responses, SAT Errors = Shifting Attention Errors, SAT RT 
Correct = Shifting Attention Reaction Time for Correct Responses, CPT Correct = CPT 
Correct Responses, CPT Omission Errors = CPT Omission Errors, CPT Comm. Errors = 
CPT Commission Errors, and CPT RT Correct = CPT Reaction Time for Correct 
Responses. 
† p < .10. 
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Table 6 
Correlations between ADHD Symptoms and CNSVS Scores (Pearson’s r)   
Dependent Variable 
 
AHDH-IA Symptoms ADHD-HI Symptoms 
Verbal Memory 
 
0.07† 0.09** 
Visual Memory 
 
0.03 0.13* 
FT Right 
 
-0.03 0.06 
FT Left 
 
0.01 0.06 
SDC Correct 
 
-0.04 0.16* 
Stroop Simple RT 
 
0.01 -0.06 
Stroop Complex Correct -0.03 -0.06 
Stroop Complex Com. 
Errors 
-0.03 -0.01 
Stroop Correct 
  
-0.01 0.07† 
Stroop RT Correct 
 
-0.01 -0.09** 
Stroop Com. Errors 
 
-0.03 -0.07† 
SAT Correct 
 
-0.03 0.08** 
SAT Errors 
 
-0.02 -0.08** 
SAT RT Correct 
 
-0.06 -0.01 
CPT Correct 
 
-0.03 -0.04 
CPT Omission Errors 0.06 0.08 
CPT Comm. Errors 
 
0.02 0.02 
CPT RT Correct 
 
0.05 0.01 
Note. ADHD symptoms based on current self symptom reports (Barkley and Murphy, 
2006).  ADHD-IA= Inattentive symptoms, ADHD-HI= Hyperactive/Impulsive symptoms.  
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FT Right = Right Finger Tapping average (number of taps), FT Left =Left Finger 
Tapping average, SDC Correct = Symbol Digit Coding Correct Responses, Stroop 
Simple RT = Stroop Simple Reaction Time, Stroop Complex Corr. = Stroop Complex 
Correct Responses, Stroop Complx. Com. Errors = Stroop Complex Commission Errors, 
Stroop Correct = Stroop Correct Responses, Stroop RT Correct = Stroop Reaction Time 
for Correct Response, Stroop Com. Errors = Stroop Commission Errors, SAT Correct 
= Shifting Attention Correct Responses, SAT Errors = Shifting Attention Errors, SAT RT 
Correct = Shifting Attention Reaction Time for Correct Responses, CPT Correct = CPT 
Correct Responses, CPT Omission Errors = CPT Omission Errors, CPT Comm. Errors = 
CPT Commission Errors, and CPT RT Correct = CPT Reaction Time for Correct 
Responses. 
** p < .01. * p < .05. † p < .10. 
 
                                                                                                             Utility of CNSVS                  73
Table 7 
Group Means (SDs) for CNSVS Variables with Age and (ADHD group only) Childhood 
Symptom Restrictions Applied 
 
Dependent Variable ADHD-U 
(n = 24) 
Anxiety 
(n = 11) 
Depression 
(n = 8) 
Control 
(n = 215) 
ADHD-CL 
(n = 14) 
Verbal Memory 
 
54.25 
 (3.98) 
52.45 
(5.66) 
51.75 
(3.15) 
53.58 
(4.48) 
54.43 
(2.98) 
Visual Memory 
 
46.33 
(5.47) 
45.27 
(6.2) 
47 
(3.7) 
47.93 
(5.11) 
48.07  
(3.6) 
FT Right 
 
60.1 
(9.27) 
62.61 
(7.78) 
63.13 
(6.26) 
62.53 
(6.89) 
59.52 
(9.08) 
FT Left 
 
56.47 
(8.29) 
59.21 
(6.81) 
60.38 
(6.21) 
57.4 
(6.96) 
55.81 
(7.81) 
SDC Correct 
 
62.08 
(11.03) 
61.82 
(10.94) 
60.38 
(11.82) 
64 
(10.3) 
58.43 
 (15.48) 
Stroop Simple RT 330.42 
(112.43) 
272.27 
(19.4) 
273.88 
(37.75) 
278.48 
(51.38) 
279.57 
(42.79) 
Stroop Complex 
Corr. 
11.92 
(0.41) 
12 
(0.00) 
12.00 
(0.00) 
11.97 
(0.19) 
11.93 
(0.27) 
Stroop Complx. 
Com.  
0.21 
(0.51) 
0.45 
(0.69) 
0.25 
(0.46) 
0.31 
(0.69) 
0.36 
(0.5) 
Stroop Correct 23.96 23.73 24 23.79 23.93 
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  (0.2) (0.47) (0.00) (1.61) (0.27) 
Stroop RT Correct 
665.04 
(98.77) 
660.36 
(74.8) 
643 
(71.84) 
668.08 
(112.19) 
683.93 
(154.91) 
Stroop Com. Errors 1.04 
(1.16) 
1.18 
(0.75) 
1.62 
(1.18) 
1.51 
(2.08) 
1.71 
(1.2) 
SAT Correct 
 
53 
(6.76) 
56.36 
(9.38) 
55.5 
(7.39) 
55.12 
(7.45) 
50.93  
(11.13) 
SAT Errors 
 
4.79 
(3.41) 
4.09 
(2.91) 
4.5 
(2.33) 
5.55 
(5.63) 
5.21  
(5.22) 
SAT RT Correct 1066.63 
(124.41) 
1012.63 
(193.53) 
1067.48 
(213.14) 
999.2 
(130.37) 
1115.81 
(201.15) 
CPT Correct 
 
39.42 
(1.06) 
39.82 
(0.4) 
39.88 
(1.81) 
39.61 
(2.45) 
38.36  
(1.15) 
CPT Omission 
Errors 
0.58 
(1.06) 
0.18 
(0.41) 
1.12 
(1.81) 
0.39 
(2.45) 
0.64 
(1.15) 
CPT Comm. Errors 0.58 
(1.06) 
0.45 
(0.69) 
1.75 
(2.32) 
1.27 
(7.33) 
0.43 
(0.94) 
CPT RT Correct 437.79 
(90.58) 
421.91 
(27.97) 
428.38 
(65.87) 
416.38 
(49.56) 
423.29 
(58.17) 
Note. FT Right = Right Finger Tapping average (number of taps), FT Left =Left Finger 
Tapping average, SDC Correct = Symbol Digit Coding Correct Responses, Stroop 
Simple RT = Stroop Simple Reaction Time, Stroop Complex Corr. = Stroop Complex 
Correct Responses, Stroop Complx. Com. = Stroop Complex Commission Errors, Stroop 
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Correct = Stroop Correct Responses, Stroop RT Correct = Stroop Reaction Time for 
Correct Response, Stroop Com. Errors = Stroop Commission Errors, SAT Correct = 
Shifting Attention Correct Responses, SAT Errors = Shifting Attention Errors, SAT RT 
Correct = Shifting Attention Reaction Time for Correct Responses, CPT Correct = CPT 
Correct Responses, CPT Omission Errors = CPT Omission Errors, CPT Comm. Errors = 
CPT Commission Errors, CPT RT Correct = CPT Reaction Time for Correct Responses, 
ADHD-CL = ADHD-U subgroup meeting ADHD impairment criteria for childhood 
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Appendix A—IRB Approval 
 
To: Will Canu  
Psychology  
CAMPUS MAIL 
 
From: _____________________________________ 
           Jay W. Cranston, M.D., Chair, Institutional Review Board  
 
Date: 4/27/2009  
 
RE: Notice of IRB Exemption  
 
Study #: 09-0234  
Study Title: The Utility of CNS Vital Signs as an Indicator of Adult ADHD  
Exemption Category: (4) Collection or Study of Existing Data  
 
 
This submission has been reviewed by the above IRB Office and was determined to be exempt from further review 
according to the regulatory category cited above under 45 CFR 46.101(b). Should you change any aspect of the proposal, 
you must contact the IRB before implementing the changes to make sure the exempt status will continue. Otherwise, you 
will not need to apply for annual approval renewal. Please notify the IRB Office when you have completed the study.  
 
 
 
CC: 
Jared Cook, Psychology  
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Appendix B—Diagnostic Items 
 
ADHD Self-Report Items 
Items Assessing Inattention: 
• Failed to give close attention to details or make careless mistakes in my work. 
• Had difficulty sustaining my attention in tasks or fun activities 
• Didn’t listen when spoken to directly 
• Didn’t follow through on instructions and failed to finish work 
• Had difficulty organizing tasks and activities 
• Avoided, disliked, or was reluctant to engage in work that requires sustained 
mental effort 
• Lost things necessary for tasks or activities. 
• Was easily distracted. 
• Was forgetful in daily activities. 
Items Assessing Hyperactivity/Impulsivity: 
• Fidgeted with hands or feet or squirm in seat. 
• Left my seat in situation in which sitting is expected. 
• Felt restless. 
• Had difficulty engaging in leisure activities or doing fun things quietly. 
• Felt “on the go” or “driven by a motor.” 
• Talked excessively. 
• Blurted our answers before questions have been completed. 
• Had difficulty awaiting turn. 
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• Interrupted or intruded on others. 
Items Assessing Adult Symptoms: 
• Am often easily distracted by extraneous stimuli. 
• Make decisions impulsively. 
• Have difficulty stopping activities or behavior when I should do so. 
• Start a project or task without reading or listening to directions carefully. 
• Show poor follow-through on promises or commitments made to others. 
• Have trouble doing things in the proper order or sequence. 
• More likely to drive a motor vehicle much faster than others (excessive speeding). 
BSI Items 
Items Assessing Depression: 
• Thoughts of Ending your Life 
• Feeling Lonely 
• Feeling blue 
• Feeling no interests in things 
• Feeling hopeless about the future 
• Feelings of worthlessness 
Items Assessing Anxiety: 
• Nervousness or shakiness inside 
• Suddenly scared for no reason 
• Feeling tense or keyed up 
• Spells of terror or panic  
• Feeling so restless you couldn’t sit still 
                                                                                                             Utility of CNSVS                  79
Appendix C—Consent 
 
Consent Form for Human Subjects 
 
Quercetin, Upper Respiratory Tract Infection, Inflammation, Mental Vigilance, 
Blood Lipids, Pharmacokinetics: A Community Clinical Trial 
 
Primary Investigator: David C. Nieman, Dr. PH, Director of the Human Performance 
Laboratory, Appalachian State University (ASU); niemandc@appstate.edu 
Research Project Managers: 
Sarah Gross, MS; Melanie Austin, MS 
Co-Investigators: 
Dru Henson, PhD (immunologist) 
Jean-Pierre Kinet, MD (immunologist) 
Steven McAnulty, PhD (oxidative stress) 
John Quindry, PhD (oxidative stress researcher) 
Josh Broman-Fulks, PhD and Will Canu, PhD (psychologists) 
Tom Lines (CEO, Quercegen Pharma) 
 
I. PURPOSE OF THIS RESEARCH PROJECT 
 Quercetin is a unique molecule found in some plant foods such as apples, berries, 
peppers, black tea, and onions. Quercetin is a powerful antioxidant (5 times more 
powerful than vitamin C), reduces inflammation, helps regulate the immune system, 
prevents some types of viruses and bacteria from multiplying, and has caffeine-like 
effects on the brain. Few studies with humans, however, have been conducted and most 
of these quercetin-related effects have come from laboratory cell culture and animal 
studies. Most people ingest about 20 mg of quercetin a day (the equivalent amount found 
in two large apples). Scientists have shown that people eating high compared to low 
amounts of quercetin have a reduced risk of developing heart disease, type 2 diabetes, 
asthma, lung cancer, colorectal cancer, and prostate cancer. In a previous study conducted 
at Appalachian State University, endurance athletes ingesting large amounts of quercetin 
(1,000 mg/day for three weeks) experienced improved mental vigilance and reduced 
illness rates when subjected to stressful amounts of exercise. The primary purpose of this 
study is to determine if 500 or 1,000 mg quercetin per day compared to placebo during a 
12-week period reduced inflammation, oxidative stress, illness, and blood lipids while 
improving mental function, cognition, and mood. 
 
II. PROCEDURES 
 One thousand non-institutionalized males and females, 18-75 years of age, will be 
recruited through mass advertisement in the Boone, NC area. Female subjects must not 
be or expect to be pregnant or lactating during the study period, January to April, 2008 
(and for the second group, September to December, 2008). You must agree to avoid any 
other supplements containing quercetin. No other restrictions will be placed on diet, 
supplement usage, or medications, but you will list all current use of supplements and 
medication in a questionnaire. Subjects with no known disease will randomized to one of 
three groups: Quercetin-500 (500 mg/day), quercetin-1000 (1000 mg/day), or placebo. 
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Subjects with known diseases (e.g., heart disease, cancer, type 2 diabetes, osteoporosis, 
arthritis) will be randomized into one of two groups: Quercetin-1000 or placebo. You will 
ingest two soft chew supplements twice daily: in the morning after waking, and then 
again between 2:00 pm and the last meal of the day. This will continue each day during a 
12-week period. 
 You will come to the ASU Human Performance Laboratory (Holmes Convocation 
Center, Room 054, 111 Rivers Street, Boone, NC; phone 828-262-3142) for two 
appointments at the beginning and end of the 12-week period. In each of these sessions, 
you must come to the lab not having consumed food or beverage (other than water) for 9-
12 hours, and then provide a blood sample (45 ml or 3 tablespoons). Your resting blood 
pressure will also be measured. Questionnaires will be administered in both sessions to 
provide basic demographic and lifestyle habits, and psychological status. The blood 
samples will be assayed for a wide variety of measures including blood lipids, 
inflammation indicators such as C-reactive protein (CRP) and cytokines, oxidative stress, 
and quercetin. These results will be shared with you free-of-charge after the study is 
completed. 
 You will start ingesting supplements immediately after the first blood sample and 
continue for 12 weeks. During the 12-week supplementation period, you will record 
illness symptoms each day using a validated questionnaire called the Wisconsin Upper 
Respiratory Symptom Survey. Every four weeks, you will record quality of life measures, 
gastrointestinal and other health symptoms.  
 
III. RISKS 
 The amount of blood drawn during each of the two sampling appointments (~45 
ml) does not have a negative influence on health. A small amount of bruising at the blood 
sample site on your arm may be experienced for several days. 
 Universal precautions will be used throughout all blood sample collections. This 
refers to a “mindset” or “attitude” taken by the researchers that assumes all blood or body 
tissues are potentially infectious. 
 In limited human studies using similar quantities of quercetin supplements, 
subjects did not experience any measurable adverse effects to their health. 
 
IV. BENEFITS 
 You will receive results of all tests when they become available. Summaries of 
the study will be e-mailed and/or mailed to you. This study will help determine if 
quercetin compared to placebo supplements are effective in improving mental function, 
cognition and mood, lowering blood lipids, reducing inflammation, reducing oxidative 
stress, reducing illness, and reducing the incidence and duration or upper respiratory tract 
infections such as the common cold. You will also receive compensation as described in 
the compensation section of this consent form. This study is not designed to measure 
change in disease status for subjects with known disease. Should the experiments notice 
any changes in disease status, such changes will be shared with the involved subjects. 
 
V. EXTENT OF ANONYMITY AND CONFIDENTIALITY 
 Your identity will not be disclosed in any published documents or shared with 
anyone but the experimenters without your express written permission. No mass e-mails 
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will be sent to subjects that display all recipients to everyone. Mass e-mails will be sent 
by placing the subjects’ e-mail addressed in the BCC area. Additionally, the names of 
participants will not be publicly displayed. 
 
VI. COMPENSATION 
 Subjects will receive $300 for completing all aspects of the study. If you drop out 
of the study for any reason, you will be compensated according to the percentage of study 
requirements completed. For example, if you complete half of the study requirements, 
you will receive $150. 
 You may at any time choose to discontinue participation in this study and will not 
be expected to continue against your will. If as a result of this research project, the 
investigator determines that you should seek counseling or medical treatment, a list of 
local services will be provided. In the event of physical injury resulting from the research 
procedures, immediate first-aid is provided free of charge. No funds have been set aside 
for medical treatment of any injury or illness resulting from this project. 
 
VII. FREEDOM TO WITHDRAW 
 You are free to withdraw from this study at any time without penalty subject to 
the terms described under “compensation” above. 
 
VIII. APPROVAL OF RESEARCH 
 This research project has been approved, as required, by the Institutional Review 
Board of Appalachian State University. The investigators have no financial interest in 
this research project. 
 
IX. SUBJECTS RESPONSIBILITIES 
I voluntarily agree to participate in this study. I have the following responsibilities: 
 
1. SUPPLEMENTATION: 
a. If you are subject without known disease, you agree to be randomized to one of 
three groups: Quercetin-500 (500 mg/day), quercetin-1000 (1000 mg/day), or 
placebo. 
b. If you are a subject with known disease, you agree to be randomized to one of 
two groups: Quercetin-1000 (1000 mg/day), or placebo. 
c. All subjects agree to avoid any other supplements containing quercetin. No 
other restrictions will be placed on diet, supplement usage, or medications, but 
you will list all current use of supplements and medication in a questionnaire.  
d. You will ingest two soft chew supplements twice daily: in the morning after 
waking, and then again between 2:00pm and the last mean of the day. This will 
continue each day during a 12-week period. 
 
2. TWO LABORATORY SESSIONS, ASU HUMAN PERFORMANCE LAB: 
a. You agree to the ASU Human Performance Laboratory for two appointments at 
the beginning and end of the 12-week period. 
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b. In each of these sessions, you agree to come to the lab not having consumed 
food or beverage (other than water) for 9-12 hours, and then provide a blood 
sample. You also agree to have your blood pressure measured. 
c. In each of these sessions, you agree to fill in questionnaires to provide basic 
demographic and lifestyle habits. You also agree to have your psychological 
status and cognition tested using a computerized software package. 
 
3. MONITORING DURING THE 12-WEEK STUDY: 
a. During the 12-week supplementation period, you agree to record illness 
symptoms each day using a validated questionnaire. 
b. Every four weeks during the study, you agree to provide answers regarding 
quality of life measures, gastrointestinal and other healthy symptoms, and other 
questions brought to your attention by the investigators.  
 
X.  SUBJECT’S PERMISSION 
I have read and understand the Informed Consent and conditions of this project. I have 
had all my questions answered. I hereby acknowledge the above and give my voluntary 
consent: 
 
__________________________________________  Date 
_________________________ 
Subject Signature 
 
 
__________________________________________  Date 
_________________________ 
Subject printed name 
 
 
__________________________________________  Date 
_________________________ 
Witness (optional except for certain classes of subjects) 
 
Should I have any questions about this research or its conduct, I may contact: 
 
David C. Nieman  828-262-6318  niemandc@appstate.edu 
Investigator   Telephone  E-mail 
 
 
Robert L. Johnson  828-262-2692  johnsonrl@appstate.edu 
Administrator, IRB   Telephone  E-mail 
Graduate Studies & Research 
Appalachian State University, Boone, NC 26608 
 
 
Retain a copy for your records. 
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Vitae 
Jared Cook attended Northeast Guilford high school in Mcleansville, North Carolina.  He 
graduated with a Bachelor of Arts Degree in English from the University of North 
Carolina at Greensboro in 2004 and a Bachelor of Arts Degree in Psychology from the 
same university in 2008.  Jared presented a poster in Seattle at the 2009 conference for 
the International Society for Research in Child and Adolescent Psychopathology.  He 
presented another poster in Chattanooga at the 2010 conference for the Southeastern 
Psychological Association, and he was first author for a poster presented at the 2010 
Association for Behavioral and Cognitive Therapies conference in San Francisco.   
    In fulfillment of program requirements at Appalachian State University, Jared 
completed his internship at the Wake Forest Baptist Medical Center Neuropsychology 
Clinic, focusing on psychological assessments. He will pursue a PhD in clinical 
psychology. 
 
 
 
 
 
 
